| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.962 | 0.004 | 0.962 | Cyclophilin D inhibitor | 0.402 0.089 DBMET00484 0.863 0.005 DBMET02241 | ||
| 0.923 | 0.003 | 0.923 | Antioxidant | 0.298 0.062 DBMET00484 0.293 0.064 DBMET02241 | ||
| 0.893 | 0.005 | 0.893 | Antiinflammatory | 0.261 0.255 DBMET00484 0.646 0.042 DBMET02241 | ||
| 0.867 | 0.003 | 0.867 | Angiogenesis stimulant | 0.321 0.042 DBMET00484 0.246 0.072 DBMET02241 | ||
| 0.851 | 0.004 | 0.851 | Hypoglycemic | 0.406 0.027 DBMET00484 0.815 0.004 DBMET02241 | ||
| 0.83 | 0.007 | 0.83 | Caspase 9 stimulant | 0.654 0.029 DBMET00484 0.391 0.117 DBMET00489 0.546 0.046 DBMET02241 | ||
| 0.816 | 0.002 | 0.877 | Alpha-N-acetylglucosaminidase inhibitor | 0.854 0.002 DBMET00484 0.677 0.003 DBMET00489 0.877 0.001 DBMET02241 | DBMET02241 | |
| 0.805 | 0.001 | 0.805 | Triose-phosphate isomerase inhibitor | 0.556 0.002 DBMET00484 0.31 0.005 DBMET00489 0.598 0.002 DBMET02241 | ||
| 0.807 | 0.004 | 0.807 | Immunomodulator | 0.255 0.111 DBMET02241 | ||
| 0.777 | 0.004 | 0.777 | Cholesterol antagonist | 0.612 0.017 DBMET00484 0.314 0.082 DBMET00489 0.636 0.014 DBMET02241 | ||
| 0.755 | 0.001 | 0.755 | Phosphofructokinase-1 inhibitor | 0.324 0.005 DBMET00484 0.227 0.009 DBMET00489 0.412 0.003 DBMET02241 | ||
| 0.754 | 0.005 | 0.754 | Antibacterial | 0.343 0.106 DBMET00484 0.298 0.137 DBMET00489 0.355 0.099 DBMET02241 | ||
| 0.752 | 0.005 | 0.752 | Vasodilator, peripheral | 0.494 0.029 DBMET00484 0.21 0.164 DBMET00489 0.634 0.012 DBMET02241 | ||
| 0.752 | 0.005 | 0.752 | Nitric oxide antagonist | 0.233 0.057 DBMET00484 0.221 0.06 DBMET00489 0.179 0.077 DBMET02241 | ||
| 0.749 | 0.004 | 0.749 | Immunosuppressant | 0.427 0.054 DBMET00484 0.326 0.099 DBMET00489 0.495 0.034 DBMET02241 | ||
| 0.742 | 0.004 | 0.742 | Apoptosis antagonist | 0.442 0.029 DBMET00484 0.326 0.069 DBMET02241 | ||
| 0.742 | 0.005 | 0.742 | Free radical scavenger | 0.265 0.063 DBMET00484 0.237 0.074 DBMET00489 0.19 0.106 DBMET02241 | ||
| 0.737 | 0.003 | 0.737 | Amylase inhibitor | 0.335 0.014 DBMET00484 0.174 0.054 DBMET00489 0.37 0.011 DBMET02241 | ||
| 0.734 | 0.001 | 0.734 | Hexokinase inhibitor | 0.203 0.033 DBMET00484 0.145 0.085 DBMET00489 0.205 0.032 DBMET02241 | ||
| 0.749 | 0.023 | 0.749 | Apoptosis agonist | 0.271 0.194 DBMET00484 0.43 0.1 DBMET02241 | ||
| 0.695 | 0.003 | 0.695 | Interleukin agonist | 0.445 0.013 DBMET00484 0.255 0.075 DBMET00489 0.433 0.014 DBMET02241 | ||
| 0.683 | 0.005 | 0.683 | DNA synthesis inhibitor | 0.401 0.021 DBMET00484 0.269 0.056 DBMET00489 0.387 0.023 DBMET02241 | ||
| 0.66 | 0.004 | 0.66 | Hepatoprotectant | 0.285 0.034 DBMET00484 0.309 0.027 DBMET02241 | ||
| 0.651 | 0.002 | 0.651 | Selectin antagonist | 0.086 0.034 DBMET00484 0.247 0.008 DBMET02241 | ||
| 0.654 | 0.01 | 0.672 | 5 Hydroxytryptamine release stimulant | 0.627 0.012 DBMET00484 0.428 0.04 DBMET00489 0.672 0.009 DBMET02241 | DBMET02241 | |
| 0.642 | 0.002 | 0.642 | Phosphorylase inhibitor | 0.061 0.024 DBMET00484 0.121 0.01 DBMET02241 | ||
| 0.64 | 0.005 | 0.64 | Tumour necrosis factor alpha release inhibitor | |||
| 0.633 | 0.001 | 0.633 | UDP-glucose 4-epimerase inhibitor | 0.412 0.005 DBMET00484 0.324 0.009 DBMET00489 0.389 0.006 DBMET02241 | ||
| 0.632 | 0.013 | 0.632 | Immunostimulant | 0.348 0.065 DBMET00484 0.402 0.049 DBMET02241 | ||
| 0.622 | 0.029 | 0.622 | Transcription factor NF kappa B inhibitor | 0.361 0.074 DBMET00484 0.351 0.077 DBMET02241 | ||
| 0.624 | 0.049 | 0.624 | Alpha-glucosidase inhibitor | |||
| 0.571 | 0.007 | 0.571 | Vasodilator | 0.246 0.071 DBMET00484 0.229 0.083 DBMET00489 0.33 0.039 DBMET02241 | ||
| 0.575 | 0.019 | 0.575 | Antithrombotic | 0.439 0.04 DBMET00484 0.488 0.031 DBMET02241 | ||
| 0.56 | 0.004 | 0.56 | Interleukin 2 agonist | 0.425 0.021 DBMET00484 0.405 0.026 DBMET02241 | ||
| 0.55 | 0.001 | 0.55 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.219 0.006 DBMET00484 0.154 0.008 DBMET00489 0.247 0.005 DBMET02241 | ||
| 0.552 | 0.004 | 0.552 | Antineoplastic antibiotic | 0.075 0.061 DBMET00484 0.124 0.037 DBMET02241 | ||
| 0.53 | 0.003 | 0.53 | NADH dehydrogenase inhibitor | 0.386 0.005 DBMET00484 0.249 0.008 DBMET00489 0.409 0.004 DBMET02241 | ||
| 0.497 | 0.004 | 0.497 | Expectorant | 0.275 0.01 DBMET00484 0.111 0.058 DBMET00489 0.458 0.004 DBMET02241 | ||
| 0.499 | 0.007 | 0.499 | Melanin inhibitor | 0.244 0.029 DBMET00484 0.156 0.074 DBMET00489 0.215 0.036 DBMET02241 | ||
| 0.516 | 0.027 | 0.516 | Angiogenesis inhibitor | |||
| 0.498 | 0.016 | 0.498 | Vasodilator, coronary | 0.386 0.04 DBMET00484 0.222 0.161 DBMET00489 0.458 0.022 DBMET02241 | ||
| 0.499 | 0.02 | 0.499 | Caspase 3 stimulant | 0.233 0.129 DBMET00484 0.198 0.172 DBMET02241 | ||
| 0.473 | 0 | 0.473 | Glucose-6-phosphate isomerase inhibitor | 0.165 0.002 DBMET00484 0.121 0.003 DBMET00489 0.221 0.001 DBMET02241 | ||
| 0.474 | 0.004 | 0.474 | Peptidyltransferase inhibitor | 0.302 0.024 DBMET00484 0.324 0.017 DBMET02241 | ||
| 0.496 | 0.03 | 0.581 | Histamine release inhibitor | 0.557 0.015 DBMET00484 0.379 0.086 DBMET00489 0.581 0.012 DBMET02241 | DBMET02241 | |
| 0.473 | 0.012 | 0.473 | RNA-directed DNA polymerase inhibitor | 0.397 0.018 DBMET00484 0.264 0.042 DBMET00489 0.341 0.025 DBMET02241 | ||
| 0.454 | 0.002 | 0.454 | Mannose-6-phosphate isomerase inhibitor | 0.242 0.014 DBMET00484 0.188 0.038 DBMET00489 0.288 0.006 DBMET02241 | ||
| 0.455 | 0.007 | 0.455 | Platelet adhesion inhibitor | 0.326 0.026 DBMET00484 0.147 0.109 DBMET02241 | ||
| 0.445 | 0.005 | 0.445 | Topoisomerase I inhibitor | 0.149 0.041 DBMET00489 | ||
| 0.453 | 0.017 | 0.6 | Hypolipemic | 0.397 0.026 DBMET00484 0.6 0.007 DBMET02241 | DBMET02241 | |
| 0.439 | 0.009 | 0.439 | Interferon gamma antagonist | 0.298 0.02 DBMET00484 0.175 0.053 DBMET00489 0.283 0.023 DBMET02241 | ||
| 0.417 | 0.007 | 0.417 | Protein kinase stimulant | 0.283 0.019 DBMET00484 0.132 0.082 DBMET00489 0.275 0.021 DBMET02241 | ||
| 0.42 | 0.014 | 0.479 | Anesthetic general | 0.479 0.009 DBMET00484 0.216 0.066 DBMET00489 0.401 0.016 DBMET02241 | DBMET00484 | |
| 0.396 | 0.001 | 0.396 | Alpha-mannosidase inhibitor | 0.117 0.005 DBMET00484 0.084 0.01 DBMET00489 0.231 0.003 DBMET02241 | ||
| 0.374 | 0.002 | 0.374 | Mannosidase inhibitor | 0.105 0.005 DBMET00484 0.073 0.011 DBMET00489 0.205 0.003 DBMET02241 | ||
| 0.38 | 0.013 | 0.406 | Thrombolytic | 0.313 0.022 DBMET00484 0.406 0.011 DBMET02241 | DBMET02241 | |
| 0.363 | 0.004 | 0.363 | ATPase inhibitor | 0.235 0.018 DBMET00484 0.142 0.115 DBMET00489 0.247 0.014 DBMET02241 | ||
| 0.368 | 0.01 | 0.368 | NOS3 expression enhancer | |||
| 0.356 | 0.007 | 0.356 | Cell adhesion inhibitor | 0.315 0.009 DBMET00484 0.193 0.027 DBMET02241 | ||
| 0.36 | 0.012 | 0.36 | Topoisomerase II inhibitor | |||
| 0.361 | 0.015 | 0.361 | Diuretic | 0.199 0.044 DBMET00484 0.244 0.032 DBMET02241 | ||
| 0.373 | 0.034 | 0.373 | DNA damaging | 0.259 0.076 DBMET00484 0.179 0.135 DBMET02241 | ||
| 0.342 | 0.004 | 0.342 | Photosensitizer | 0.261 0.005 DBMET00484 0.134 0.042 DBMET00489 0.164 0.024 DBMET02241 | ||
| 0.336 | 0.002 | 0.336 | Protein 50S ribosomal subunit inhibitor | 0.053 0.037 DBMET00484 0.155 0.006 DBMET00489 0.124 0.009 DBMET02241 | ||
| 0.309 | 0.005 | 0.309 | AMP-activated protein kinase stimulant | 0.121 0.048 DBMET00484 0.151 0.028 DBMET02241 | ||
| 0.299 | 0.006 | 0.53 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.43 0.003 DBMET00484 0.267 0.008 DBMET00489 0.53 0.002 DBMET02241 | DBMET02241 | |
| 0.3 | 0.008 | 0.3 | Neurotrophic factor | |||
| 0.304 | 0.017 | 0.309 | Neurotrophic factor enhancer | 0.309 0.016 DBMET00484 0.211 0.067 DBMET00489 0.266 0.03 DBMET02241 | DBMET00484 | |
| 0.341 | 0.055 | 0.39 | Spasmolytic | 0.269 0.083 DBMET00484 0.39 0.042 DBMET02241 | DBMET02241 | |
| 0.298 | 0.013 | 0.298 | Alkylator | 0.194 0.028 DBMET00484 0.164 0.04 DBMET02241 | ||
| 0.294 | 0.013 | 0.33 | Nitric-oxide synthase stimulant | 0.326 0.007 DBMET00484 0.264 0.024 DBMET00489 0.33 0.006 DBMET02241 | DBMET02241 | |
| 0.283 | 0.004 | 0.283 | Transcription factor NF kappa B stimulant | 0.12 0.025 DBMET00484 0.114 0.029 DBMET02241 | ||
| 0.274 | 0.001 | 0.274 | Sodium/glucose cotransporter inhibitor | 0.026 0.017 DBMET00484 0.043 0.006 DBMET00489 0.026 0.017 DBMET02241 | ||
| 0.288 | 0.019 | 0.288 | Monophenol monooxygenase inhibitor | 0.182 0.037 DBMET00484 0.195 0.034 DBMET00489 0.248 0.024 DBMET02241 | ||
| 0.276 | 0.012 | 0.276 | Cell wall synthesis inhibitor | 0.261 0.014 DBMET00484 0.138 0.077 DBMET00489 0.269 0.013 DBMET02241 | ||
| 0.277 | 0.015 | 0.485 | Insulin secretagoues | 0.287 0.014 DBMET00484 0.485 0.005 DBMET02241 | DBMET02241 | |
| 0.295 | 0.044 | 0.298 | Cyclic AMP phosphodiesterase inhibitor | 0.298 0.043 DBMET00484 0.288 0.047 DBMET02241 | DBMET00484 | |
| 0.259 | 0.012 | 0.259 | Interleukin 4 antagonist | 0.168 0.036 DBMET00484 | ||
| 0.264 | 0.024 | 0.264 | Lipid peroxidase inhibitor | 0.212 0.037 DBMET00484 0.131 0.083 DBMET02241 | ||
| 0.234 | 0.002 | 0.234 | ATPase (Vacuolar H+) inhibitor | 0.111 0.027 DBMET00484 0.134 0.012 DBMET02241 | ||
| 0.228 | 0.012 | 0.24 | Cyclooxygenase 3 inhibitor | 0.24 0.01 DBMET00484 0.131 0.066 DBMET00489 0.204 0.017 DBMET02241 | DBMET00484 | |
| 0.255 | 0.04 | 0.36 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.36 0.011 DBMET00484 0.239 0.048 DBMET00489 0.302 0.023 DBMET02241 | DBMET00484 | |
| 0.219 | 0.007 | 0.219 | DNA repair enzyme inhibitor | 0.148 0.033 DBMET00484 0.117 0.079 DBMET02241 | ||
| 0.252 | 0.042 | 0.303 | Non-steroidal antiinflammatory agent | 0.303 0.028 DBMET00484 0.263 0.038 DBMET02241 | DBMET00484 | |
| 0.21 | 0.004 | 0.21 | Phosphodiesterase 6D inhibitor | 0.107 0.04 DBMET00484 0.116 0.028 DBMET02241 | ||
| 0.215 | 0.01 | 0.299 | Mucolytic | 0.267 0.005 DBMET00484 0.14 0.039 DBMET00489 0.299 0.004 DBMET02241 | DBMET02241 | |
| 0.209 | 0.005 | 0.209 | Toll-Like receptor 4 antagonist | 0.153 0.019 DBMET00484 0.156 0.018 DBMET02241 | ||
| 0.229 | 0.028 | 0.728 | Interleukin 6 antagonist | 0.163 0.072 DBMET00484 0.728 0.002 DBMET00489 0.171 0.063 DBMET02241 | DBMET00489 | |
| 0.208 | 0.007 | 0.208 | Aldose reductase inhibitor | 0.176 0.009 DBMET00484 0.084 0.022 DBMET02241 | ||
| 0.205 | 0.005 | 0.205 | Interferon agonist | 0.139 0.012 DBMET00484 0.079 0.053 DBMET00489 0.137 0.012 DBMET02241 | ||
| 0.218 | 0.023 | 0.218 | DNA polymerase I inhibitor | 0.17 0.039 DBMET00484 0.172 0.038 DBMET02241 | ||
| 0.217 | 0.027 | 0.29 | Hemostatic | 0.164 0.053 DBMET00484 0.29 0.017 DBMET02241 | DBMET02241 | |
| 0.19 | 0.001 | 0.19 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.016 DBMET00484 0.055 0.005 DBMET00489 0.027 0.017 DBMET02241 | ||
| 0.181 | 0.006 | 0.218 | Ca2+-transporting ATPase inhibitor | 0.218 0.002 DBMET00484 0.187 0.005 DBMET00489 0.193 0.004 DBMET02241 | DBMET00484 | |
| 0.172 | 0.006 | 0.193 | Glutamate release inhibitor | 0.166 0.007 DBMET00484 0.111 0.029 DBMET00489 0.193 0.005 DBMET02241 | DBMET02241 | |
| 0.162 | 0.004 | 0.162 | Na+ K+ transporting ATPase inhibitor | 0.117 0.018 DBMET00484 0.123 0.015 DBMET00489 0.11 0.023 DBMET02241 | ||
| 0.181 | 0.025 | 0.252 | Adenylate cyclase stimulant | 0.252 0.004 DBMET00484 0.185 0.022 DBMET00489 0.223 0.006 DBMET02241 | DBMET00484 | |
| 0.157 | 0.006 | 0.157 | Glycine receptor antagonist | 0.145 0.009 DBMET00484 0.109 0.025 DBMET00489 0.118 0.019 DBMET02241 | ||
| 0.175 | 0.026 | 0.175 | Xanthine oxidase inhibitor | 0.154 0.033 DBMET00484 0.155 0.033 DBMET02241 | ||
| 0.15 | 0.001 | 0.15 | Antibiotic Aminoglycoside-like | 0.035 0.028 DBMET02241 | ||
| 0.153 | 0.004 | 0.153 | Interferon inducer | 0.109 0.009 DBMET00484 0.066 0.041 DBMET00489 0.107 0.01 DBMET02241 | ||
| 0.146 | 0.003 | 0.146 | Heparanase inhibitor | 0.072 0.01 DBMET00484 0.051 0.044 DBMET00489 0.066 0.015 DBMET02241 | ||
| 0.168 | 0.024 | 0.169 | Vanilloid 1 agonist | 0.169 0.024 DBMET00484 0.125 0.075 DBMET00489 0.157 0.032 DBMET02241 | DBMET00484 | |
| 0.151 | 0.012 | 0.151 | Interleukin 12 antagonist | |||
| 0.159 | 0.025 | 0.159 | Mediator release inhibitor | 0.145 0.031 DBMET00484 0.135 0.036 DBMET02241 | ||
| 0.134 | 0.005 | 0.134 | Factor IXa inhibitor | |||
| 0.147 | 0.018 | 0.149 | Thioredoxin inhibitor | 0.149 0.017 DBMET00484 | DBMET00484 | |
| 0.151 | 0.026 | 0.393 | Adenylate kinase inhibitor | 0.383 0.004 DBMET00484 0.276 0.008 DBMET00489 0.393 0.003 DBMET02241 | DBMET02241 | |
| 0.143 | 0.024 | 0.143 | Topoisomerase II alpha inhibitor | |||
| 0.122 | 0.007 | 0.122 | Carbonic anhydrase XIV inhibitor | 0.078 0.017 DBMET00484 0.051 0.032 DBMET02241 | ||
| 0.143 | 0.028 | 0.143 | Beta glucuronidase inhibitor | 0.111 0.055 DBMET00484 | ||
| 0.117 | 0.002 | 0.117 | Protein 30S ribosomal subunit inhibitor | 0.064 0.005 DBMET00489 | ||
| 0.189 | 0.075 | 0.189 | Growth factor agonist | |||
| 0.176 | 0.063 | 0.176 | Anticoagulant | 0.134 0.096 DBMET00484 0.148 0.083 DBMET02241 | ||
| 0.123 | 0.011 | 0.146 | Neuraminidase (influenza) inhibitor | 0.073 0.031 DBMET00484 0.146 0.008 DBMET02241 | DBMET02241 | |
| 0.125 | 0.015 | 0.493 | Carbamoyl phosphate synthetase inhibitor | 0.382 0.003 DBMET00484 0.222 0.006 DBMET00489 0.493 0.002 DBMET02241 | DBMET02241 | |
| 0.115 | 0.006 | 0.115 | Glucosylceramidase inhibitor | 0.053 0.041 DBMET00484 0.05 0.048 DBMET00489 0.052 0.043 DBMET02241 | ||
| 0.15 | 0.045 | 0.219 | Adenylate cyclase inhibitor | 0.219 0.023 DBMET00484 0.205 0.025 DBMET02241 | DBMET00484 | |
| 0.145 | 0.045 | 0.145 | DNA intercalator | |||
| 0.133 | 0.033 | 0.137 | Sphingomyelinase inhibitor | 0.126 0.037 DBMET00484 0.107 0.052 DBMET00489 0.137 0.031 DBMET02241 | DBMET02241 | |
| 0.134 | 0.035 | 0.189 | Carbonic anhydrase III inhibitor | 0.189 0.018 DBMET00484 0.115 0.048 DBMET00489 0.138 0.034 DBMET02241 | DBMET00484 | |
| 0.141 | 0.043 | 0.225 | Microtubule formation inhibitor | 0.216 0.016 DBMET00484 0.123 0.058 DBMET00489 0.225 0.015 DBMET02241 | DBMET02241 | |
| 0.121 | 0.023 | 0.121 | Interleukin 5 antagonist | |||
| 0.113 | 0.015 | 0.233 | Glycine receptor agonist | 0.233 0.003 DBMET00484 0.114 0.014 DBMET00489 0.152 0.007 DBMET02241 | DBMET00484 | |
| 0.181 | 0.092 | 0.262 | DNA methylase inhibitor | 0.262 0.042 DBMET00484 0.226 0.063 DBMET02241 | DBMET00484 | |
| 0.118 | 0.03 | 0.165 | Carbonic anhydrase XIII inhibitor | 0.165 0.019 DBMET00484 0.066 0.062 DBMET00489 0.106 0.035 DBMET02241 | DBMET00484 | |
| 0.086 | 0.003 | 0.086 | Antibiotic Macrolide-like | |||
| 0.135 | 0.052 | 0.135 | CC chemokine 6 receptor antagonist | 0.123 0.099 DBMET00484 | ||
| 0.082 | 0.003 | 0.082 | Guanylate cyclase inhibitor | 0.072 0.004 DBMET00484 0.066 0.007 DBMET00489 0.068 0.005 DBMET02241 | ||
| 0.103 | 0.026 | 0.103 | Histone deacetylase SIRT1 stimulant | |||
| 0.103 | 0.026 | 0.103 | Histone deacetylase stimulant | |||
| 0.095 | 0.017 | 0.139 | Neuraminidase inhibitor | 0.066 0.037 DBMET00484 0.139 0.007 DBMET02241 | DBMET02241 | |
| 0.269 | 0.202 | 0.642 | 5 Hydroxytryptamine release inhibitor | 0.642 0.007 DBMET00484 0.46 0.047 DBMET00489 0.626 0.008 DBMET02241 | DBMET00484 | |
| 0.073 | 0.006 | 0.073 | Cytokine production stimulant | 0.053 0.022 DBMET00484 0.052 0.024 DBMET02241 | ||
| 0.131 | 0.066 | 0.149 | Antibacterial (Helicobacter pylori) | 0.149 0.047 DBMET00484 0.109 0.1 DBMET02241 | DBMET00484 | |
| 0.068 | 0.004 | 0.068 | Uridine phosphorylase inhibitor | 0.064 0.005 DBMET00484 0.046 0.009 DBMET00489 0.062 0.005 DBMET02241 | ||
| 0.065 | 0.002 | 0.065 | Vanilloid 2 agonist | 0.043 0.004 DBMET00484 0.033 0.007 DBMET00489 0.034 0.006 DBMET02241 | ||
| 0.087 | 0.025 | 0.115 | Phospholipase D inhibitor | 0.115 0.008 DBMET00484 0.089 0.023 DBMET00489 0.097 0.016 DBMET02241 | DBMET00484 | |
| 0.062 | 0.001 | 0.062 | Telomerase stimulant | 0.032 0.003 DBMET00484 0.025 0.004 DBMET00489 0.027 0.004 DBMET02241 | ||
| 0.126 | 0.065 | 0.508 | Aldehyde dehydrogenase inhibitor | 0.508 0.004 DBMET00484 0.144 0.051 DBMET00489 0.427 0.005 DBMET02241 | DBMET00484 | |
| 0.059 | 0.003 | 0.059 | Toll-Like receptor 4 agonist | |||
| 0.143 | 0.089 | 0.198 | CF transmembrane conductance regulator agonist | 0.198 0.023 DBMET00484 0.158 0.062 DBMET00489 0.166 0.051 DBMET02241 | DBMET00484 | |
| 0.068 | 0.015 | 0.089 | Adenosine deaminase inhibitor | 0.075 0.011 DBMET00484 0.058 0.023 DBMET00489 0.089 0.007 DBMET02241 | DBMET02241 | |
| 0.072 | 0.019 | 0.078 | Lipocortins synthesis agonist | 0.078 0.015 DBMET00484 0.055 0.049 DBMET02241 | DBMET00484 | |
| 0.085 | 0.034 | 0.085 | Phosphodiesterase VI inhibitor | |||
| 0.068 | 0.017 | 0.079 | Adenine nucleotide translocase inhibitor | 0.077 0.01 DBMET00484 0.079 0.009 DBMET02241 | DBMET02241 | |
| 0.053 | 0.003 | 0.053 | Purinergic receptor agonist | |||
| 0.053 | 0.003 | 0.053 | Purinergic P2 agonist | |||
| 0.123 | 0.074 | 0.238 | Toll-Like receptor 2 antagonist | 0.238 0.011 DBMET00484 0.142 0.058 DBMET00489 0.23 0.013 DBMET02241 | DBMET00484 | |
| 0.066 | 0.018 | 0.066 | Glucose-6-phosphate translocase inhibitor | |||
| 0.052 | 0.005 | 0.052 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 DBMET00484 0.034 0.027 DBMET00489 | ||
| 0.091 | 0.045 | 0.165 | Carbonic anhydrase VI inhibitor | 0.165 0.018 DBMET00484 0.082 0.055 DBMET00489 0.089 0.048 DBMET02241 | DBMET00484 | |
| 0.045 | 0.003 | 0.045 | Purinergic P2Y agonist | |||
| 0.047 | 0.006 | 0.047 | Adenosine A1 receptor agonist | |||
| 0.082 | 0.043 | 0.542 | Glutamate dehydrogenase inhibitor | 0.407 0.004 DBMET00484 0.203 0.01 DBMET00489 0.542 0.003 DBMET02241 | DBMET02241 | |
| 0.101 | 0.061 | 0.175 | Anabolic | 0.172 0.009 DBMET00484 0.175 0.008 DBMET00489 0.158 0.014 DBMET02241 | DBMET00489 | |
| 0.052 | 0.014 | 0.094 | Arginase inhibitor | 0.094 0.004 DBMET00484 0.05 0.015 DBMET00489 0.083 0.005 DBMET02241 | DBMET00484 | |
| 0.039 | 0.002 | 0.039 | Antibiotic Anthracycline-like | 0.027 0.004 DBMET00484 0.021 0.01 DBMET00489 0.025 0.005 DBMET02241 | ||
| 0.066 | 0.029 | 0.252 | Acyl-CoA dehydrogenase inhibitor | 0.244 0.003 DBMET00484 0.187 0.006 DBMET00489 0.252 0.003 DBMET02241 | DBMET02241 | |
| 0.041 | 0.007 | 0.041 | Motilin receptor agonist | |||
| 0.044 | 0.011 | 0.052 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.05 0.009 DBMET00484 0.044 0.01 DBMET00489 0.052 0.009 DBMET02241 | DBMET02241 | |
| 0.037 | 0.005 | 0.037 | 1,3-Beta-glucan synthase inhibitor | |||
| 0.066 | 0.035 | 0.345 | Biliverdin reductase inhibitor | 0.336 0.003 DBMET00484 0.212 0.005 DBMET00489 0.345 0.003 DBMET02241 | DBMET02241 | |
| 0.082 | 0.051 | 0.222 | Cell adhesion molecule inhibitor | 0.222 0.008 DBMET00484 0.134 0.019 DBMET02241 | DBMET00484 | |
| 0.108 | 0.079 | 0.125 | Beta amyloid protein antagonist | 0.125 0.063 DBMET00484 | DBMET00484 | |
| 0.161 | 0.133 | 0.516 | Platelet antagonist | 0.516 0.012 DBMET00484 0.447 0.02 DBMET02241 | DBMET00484 | |
| 0.044 | 0.017 | 0.099 | Phosphoglycerate kinase inhibitor | 0.059 0.011 DBMET00484 0.039 0.02 DBMET00489 0.099 0.007 DBMET02241 | DBMET02241 | |
| 0.134 | 0.108 | 0.256 | Arachidonic acid antagonist | 0.256 0.005 DBMET00484 0.213 0.022 DBMET00489 0.238 0.009 DBMET02241 | DBMET00484 | |
| 0.061 | 0.036 | 0.311 | Argininosuccinate synthase inhibitor | 0.311 0.004 DBMET00484 0.177 0.009 DBMET00489 0.246 0.005 DBMET02241 | DBMET00484 | |
| 0.143 | 0.12 | 0.315 | Phospholipase C inhibitor | 0.315 0.017 DBMET00484 0.185 0.056 DBMET00489 0.302 0.018 DBMET02241 | DBMET00484 | |
| 0.052 | 0.03 | 0.084 | Antimetabolite | 0.082 0.019 DBMET00484 0.084 0.019 DBMET02241 | DBMET02241 | |
| 0.044 | 0.024 | 0.072 | Thymidine kinase inhibitor | 0.072 0.01 DBMET00484 0.044 0.024 DBMET00489 0.053 0.017 DBMET02241 | DBMET00484 | |
| 0.02 | 0.002 | 0.02 | Purinergic P2Y2 agonist | |||
| 0.086 | 0.069 | 0.254 | Alcohol dehydrogenase inhibitor | 0.254 0.007 DBMET00484 0.1 0.052 DBMET00489 0.209 0.011 DBMET02241 | DBMET00484 | |
| 0.06 | 0.044 | 0.151 | Purinergic P2X1 antagonist | 0.151 0.007 DBMET00484 0.114 0.013 DBMET00489 0.131 0.009 DBMET02241 | DBMET00484 | |
| 0.043 | 0.027 | 0.146 | Toll-Like receptor 2 agonist | 0.094 0.015 DBMET00484 0.038 0.031 DBMET00489 0.146 0.011 DBMET02241 | DBMET02241 | |
| 0.037 | 0.021 | 0.563 | Fumarate hydratase inhibitor | 0.348 0.002 DBMET00484 0.105 0.005 DBMET00489 0.563 0.002 DBMET02241 | DBMET02241 | |
| 0.052 | 0.041 | 0.052 | Carbonic anhydrase IX inhibitor | |||
| 0.026 | 0.019 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 DBMET00484 0.028 0.015 DBMET00489 0.028 0.014 DBMET02241 | DBMET00484 | |
| 0.043 | 0.037 | 0.066 | Neuraminidase (Influenza A) inhibitor | 0.054 0.019 DBMET00484 0.066 0.009 DBMET02241 | DBMET02241 | |
| 0.017 | 0.011 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | |||
| 0.078 | 0.074 | 0.081 | T cell inhibitor | 0.081 0.06 DBMET02241 | DBMET02241 | |
| 0.019 | 0.015 | 0.019 | Inosine monophosphate dehydrogenase 1 inhibitor | |||
| 0.022 | 0.018 | 0.031 | Isoleucine-tRNA ligase inhibitor | 0.031 0.005 DBMET00484 0.023 0.015 DBMET00489 0.031 0.005 DBMET02241 | DBMET02241 | |
| 0.075 | 0.071 | 0.172 | Glutathione S-transferase inhibitor | 0.149 0.012 DBMET00484 0.074 0.073 DBMET00489 0.172 0.008 DBMET02241 | DBMET02241 | |
| 0.025 | 0.021 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.017 DBMET00484 0.027 0.015 DBMET00489 | DBMET00489 | |
| 0.014 | 0.013 | 0.019 | Purinergic P2Y1 agonist | 0.019 0.007 DBMET00484 0.017 0.009 DBMET00489 0.017 0.009 DBMET02241 | DBMET00484 | |
| 0.056 | 0.056 | 0.081 | Nitric oxide donor | 0.081 0.022 DBMET00484 0.076 0.026 DBMET02241 | DBMET00484 | |
| 0.129 | 0.129 | 0.173 | Heat shock protein 70 antagonist | 0.173 0.015 DBMET00484 0.145 0.059 DBMET00489 0.157 0.031 DBMET02241 | DBMET00484 | |
| 0.052 | 0.053 | 0.053 | Carbonic anhydrase inhibitor | 0.053 0.052 DBMET00484 | DBMET00484 | |
| 0.04 | 0.041 | 0.062 | Microtubule stabilization | 0.062 0.012 DBMET00484 0.055 0.021 DBMET02241 | DBMET00484 | |
| 0.051 | 0.052 | 0.102 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.088 0.021 DBMET00484 0.102 0.016 DBMET02241 | DBMET02241 | |
| 0.036 | 0.037 | 0.038 | Growth hormone release inhibitor | 0.038 0.034 DBMET02241 | DBMET02241 | |
| 0.014 | 0.016 | 0.028 | Ileal bile acid transport inhibitor | 0.028 0.005 DBMET00484 0.026 0.006 DBMET02241 | DBMET00484 | |
| 0.046 | 0.048 | 0.055 | Factor III inhibitor | 0.055 0.024 DBMET00484 | DBMET00484 | |
| 0.044 | 0.046 | 0.231 | Ornithine carbamoyltransferase inhibitor | 0.23 0.006 DBMET00484 0.116 0.013 DBMET00489 0.231 0.006 DBMET02241 | DBMET02241 | |
| 0.018 | 0.021 | 0.02 | Corticosteroid-like | 0.02 0.017 DBMET00484 | DBMET00484 | |
| 0.088 | 0.093 | 0.321 | Cystathionine beta-synthase inhibitor | 0.321 0.008 DBMET00484 0.224 0.019 DBMET00489 0.24 0.017 DBMET02241 | DBMET00484 | |
| 0.065 | 0.071 | 0.174 | GABA aminotransferase inhibitor | 0.174 0.005 DBMET00484 0.105 0.024 DBMET00489 0.14 0.01 DBMET02241 | DBMET00484 | |
| 0.016 | 0.023 | 0.03 | Methylmalonyl-CoA mutase inhibitor | 0.028 0.003 DBMET00484 0.022 0.006 DBMET00489 0.03 0.002 DBMET02241 | DBMET02241 | |
| 0.074 | 0.082 | 0.446 | Thioredoxin reductase inhibitor | 0.078 0.068 DBMET00484 0.446 0.002 DBMET00489 | DBMET00489 | |
| 0.041 | 0.058 | 0.058 | Squalene epoxidase inhibitor | 0.058 0.023 DBMET00484 0.047 0.041 DBMET00489 0.049 0.036 DBMET02241 | DBMET00484 | |
| 0.123 | 0.14 | 0.277 | DNA methyltransferase I inhibitor | 0.277 0.036 DBMET00484 0.212 0.063 DBMET02241 | DBMET00484 | |
| 0.087 | 0.107 | 0.314 | Cholesterol synthesis inhibitor | 0.264 0.016 DBMET00484 0.259 0.016 DBMET00489 0.314 0.01 DBMET02241 | DBMET02241 | |
| 0.021 | 0.047 | 0.042 | Purinergic P2Y15 antagonist | 0.041 0.006 DBMET00484 0.042 0.006 DBMET00489 0.035 0.01 DBMET02241 | DBMET00489 | |
| 0.161 | 0.202 | 0.243 | Hypoxia-inducible factor 1 alpha inhibitor | 0.243 0.107 DBMET00484 0.189 0.166 DBMET02241 | DBMET00484 | |
| 0.051 | 0.109 | 0.177 | Ornithine decarboxylase inhibitor | 0.177 0.006 DBMET00484 0.099 0.046 DBMET00489 0.144 0.013 DBMET02241 | DBMET00484 | |
| 0.033 | 0.095 | 0.091 | Topoisomerase II beta inhibitor | 0.091 0.011 DBMET00484 0.045 0.042 DBMET00489 0.073 0.015 DBMET02241 | DBMET00484 | |
| 0.004 | 0.069 | 0.045 | Lysophosphatidic acid receptor 3 agonist | 0.036 0.003 DBMET00484 0.02 0.005 DBMET00489 0.045 0.003 DBMET02241 | DBMET02241 | |
| 0.004 | 0.075 | 0.011 | Calcineurin inhibitor | 0.011 0.009 DBMET02241 | DBMET02241 | |
| 0.008 | 0.081 | 0.022 | Vitamin D receptor agonist | 0.02 0.007 DBMET00484 0.022 0.005 DBMET02241 | DBMET02241 | |
| 0.011 | 0.088 | 0.072 | Prostaglandin F2 alpha agonist | 0.056 0.004 DBMET00484 0.025 0.012 DBMET00489 0.072 0.003 DBMET02241 | DBMET02241 | |
| 0.012 | 0.089 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.008 DBMET00484 0.021 0.013 DBMET00489 0.023 0.009 DBMET02241 | DBMET00484 | |
| 0.098 | 0.177 | 0.361 | Pyruvate kinase inhibitor | 0.217 0.073 DBMET00484 0.361 0.03 DBMET02241 | DBMET02241 | |
| 0.057 | 0.14 | 0.111 | Aminoacyl-tRNA synthetase inhibitor | 0.111 0.035 DBMET02241 | DBMET02241 | |
| 0.001 | 0.087 | 0.019 | Mannitol 2-dehydrogenase inhibitor | 0.019 0.002 DBMET02241 | DBMET02241 | |
| 0.057 | 0.144 | 0.207 | Uric acid excretion stimulant | 0.207 0.012 DBMET00484 0.14 0.027 DBMET02241 | DBMET00484 | |
| 0.003 | 0.094 | 0.039 | Glutamate (mGluR6) agonist | 0.039 0.003 DBMET00484 0.02 0.004 DBMET00489 0.023 0.004 DBMET02241 | DBMET00484 | |
| 0.017 | 0.108 | 0.094 | Ribonucleotide reductase inhibitor | 0.081 0.026 DBMET00484 0.094 0.022 DBMET02241 | DBMET02241 | |
| 0.025 | 0.121 | 0.945 | Alcohol oxidase inhibitor | 0.945 0.001 DBMET00484 0.441 0.004 DBMET00489 0.9 0.002 DBMET02241 | DBMET00484 | |
| 0.103 | 0.2 | 0.388 | Insulin sensitizer | 0.272 0.024 DBMET00484 0.156 0.125 DBMET00489 0.388 0.007 DBMET02241 | DBMET02241 | |
| 0.059 | 0.157 | 0.139 | Lanosterol 14 alpha demethylase inhibitor | 0.139 0.016 DBMET00484 0.111 0.041 DBMET00489 0.139 0.016 DBMET02241 | DBMET02241 | |
| 0.052 | 0.151 | 0.322 | Protein-tyrosine phosphatase 1B inhibitor | 0.188 0.032 DBMET00484 0.322 0.009 DBMET02241 | DBMET02241 | |
| 0.025 | 0.125 | 0.16 | HIV-1 integrase (Strand Transfer) inhibitor | 0.16 0.012 DBMET00484 0.111 0.019 DBMET02241 | DBMET00484 | |
| 0.014 | 0.115 | 0.091 | HMG CoA reductase inhibitor | 0.05 0.007 DBMET00484 0.091 0.003 DBMET00489 0.077 0.004 DBMET02241 | DBMET00489 | |
| 0.016 | 0.12 | 0.093 | Ribonucleoside-diphosphate reductase inhibitor | 0.079 0.025 DBMET00484 0.093 0.021 DBMET02241 | DBMET02241 | |
| 0.083 | 0.187 | 0.228 | Phospholipase A2 inhibitor | 0.228 0.03 DBMET00484 0.213 0.036 DBMET02241 | DBMET00484 | |
| 0.023 | 0.13 | 0.075 | AICAR transformylase inhibitor | 0.075 0.008 DBMET00484 0.049 0.023 DBMET00489 0.06 0.014 DBMET02241 | DBMET00484 | |
| 0.031 | 0.139 | 0.121 | HIV-1 integrase (3'-Processing) inhibitor | 0.121 0.019 DBMET00484 0.108 0.023 DBMET02241 | DBMET00484 | |
| 0.061 | 0.17 | 0.079 | Vanilloid agonist | 0.079 0.073 DBMET00484 | DBMET00484 | |
| 0.006 | 0.124 | 0.062 | Prostaglandin EP2 agonist | 0.046 0.007 DBMET00484 0.062 0.004 DBMET02241 | DBMET02241 | |
| 0.002 | 0.121 | 0.028 | Thromboxane agonist | 0.022 0.004 DBMET00484 0.028 0.003 DBMET02241 | DBMET02241 | |
| 0.032 | 0.151 | 0.068 | Protein kinase C beta inhibitor | 0.068 0.052 DBMET00484 | DBMET00484 | |
| 0.026 | 0.148 | 0.077 | Leukotriene B4 antagonist | 0.065 0.023 DBMET00484 0.077 0.016 DBMET02241 | DBMET02241 | |
| 0.017 | 0.146 | 0.073 | Glutamate (mGluR3) agonist | 0.073 0.003 DBMET00484 0.042 0.008 DBMET00489 0.048 0.005 DBMET02241 | DBMET00484 | |
| 0.013 | 0.143 | 0.048 | Carbonic anhydrase I inhibitor | 0.048 0.045 DBMET00484 | DBMET00484 | |
| 0.128 | 0.259 | 0.357 | Gastrin inhibitor | 0.357 0.009 DBMET00484 0.24 0.091 DBMET00489 0.327 0.018 DBMET02241 | DBMET00484 | |
| 0.021 | 0.153 | 0.109 | Glutamate (mGluR8) agonist | 0.109 0.003 DBMET00484 0.073 0.005 DBMET00489 0.079 0.004 DBMET02241 | DBMET00484 | |
| 0.009 | 0.147 | 0.037 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 DBMET00484 0.024 0.009 DBMET00489 0.037 0.003 DBMET02241 | DBMET02241 | |
| 0.042 | 0.181 | 0.195 | Glutamate (mGluR6) antagonist | 0.195 0.003 DBMET00484 0.114 0.007 DBMET00489 0.141 0.004 DBMET02241 | DBMET00484 | |
| 0.01 | 0.151 | 0.045 | Carbonic anhydrase VII inhibitor | 0.041 0.039 DBMET00484 0.045 0.034 DBMET02241 | DBMET02241 | |
| 0.012 | 0.153 | 0.032 | Inosine monophosphate dehydrogenase inhibitor | 0.032 0.031 DBMET00484 | DBMET00484 | |
| 0.026 | 0.168 | 0.457 | Catalase inhibitor | 0.412 0.003 DBMET00484 0.427 0.003 DBMET00489 0.457 0.003 DBMET02241 | DBMET02241 | |
| 0.087 | 0.236 | 0.19 | P-glycoprotein inhibitor | 0.19 0.071 DBMET00484 0.173 0.087 DBMET02241 | DBMET00484 | |
| 0.047 | 0.196 | 0.685 | GABA C receptor agonist | 0.685 0.002 DBMET00484 0.552 0.003 DBMET00489 0.531 0.003 DBMET02241 | DBMET00484 | |
| 0.004 | 0.157 | 0.034 | Thromboxane A2 agonist | 0.032 0.003 DBMET00484 0.02 0.006 DBMET00489 0.034 0.003 DBMET02241 | DBMET02241 | |
| 0.004 | 0.157 | 0.067 | Prostacyclin agonist | 0.036 0.005 DBMET00484 0.067 0.004 DBMET02241 | DBMET02241 | |
| 0.064 | 0.217 | 0.132 | Acetylcholine release stimulant | 0.132 0.031 DBMET00484 0.102 0.083 DBMET00489 0.108 0.069 DBMET02241 | DBMET00484 | |
| 0.005 | 0.166 | 0.069 | Squalene synthetase inhibitor | 0.069 0.01 DBMET00484 0.059 0.012 DBMET02241 | DBMET00484 | |
| 0.005 | 0.17 | 0.035 | Purinergic P2T antagonist | 0.035 0.011 DBMET02241 | DBMET02241 | |
| 0.047 | 0.214 | 0.13 | Bile acid receptor antagonist | 0.13 0.013 DBMET00484 0.091 0.071 DBMET00489 0.114 0.025 DBMET02241 | DBMET00484 | |
| 0.009 | 0.176 | 0.05 | Caspase 2 inhibitor | 0.05 0.012 DBMET00484 0.033 0.021 DBMET02241 | DBMET00484 | |
| 0.026 | 0.195 | 0.057 | Fatty acid synthase inhibitor | 0.057 0.04 DBMET00484 | DBMET00484 | |
| 0.092 | 0.264 | 0.898 | Succinate dehydrogenase inhibitor | 0.547 0.003 DBMET00484 0.898 0.002 DBMET00489 0.475 0.003 DBMET02241 | DBMET00489 | |
| 0.024 | 0.196 | 0.372 | Histidine decarboxylase inhibitor | 0.368 0.004 DBMET00484 0.184 0.015 DBMET00489 0.372 0.004 DBMET02241 | DBMET02241 | |
| 0.007 | 0.183 | 0.075 | 5-Alpha-reductase inhibitor | 0.075 0.013 DBMET00484 0.032 0.031 DBMET02241 | DBMET00484 | |
| 0.022 | 0.202 | 0.117 | Androgen agonist | 0.094 0.017 DBMET00484 0.117 0.01 DBMET00489 0.062 0.038 DBMET02241 | DBMET00489 | |
| 0.075 | 0.257 | 0.357 | Interleukin antagonist | 0.169 0.104 DBMET00484 0.229 0.07 DBMET00489 0.357 0.038 DBMET02241 | DBMET02241 | |
| 0.02 | 0.203 | 0.447 | Aconitate hydratase inhibitor | 0.297 0.002 DBMET00484 0.172 0.004 DBMET00489 0.447 0.002 DBMET02241 | DBMET02241 | |
| 0.021 | 0.204 | 0.116 | Kainate receptor agonist | 0.116 0.002 DBMET00484 0.068 0.005 DBMET00489 0.085 0.003 DBMET02241 | DBMET00484 | |
| 0.019 | 0.203 | 0.046 | Cholesterol esterase inhibitor | 0.046 0.036 DBMET00484 | DBMET00484 | |
| 0.061 | 0.25 | 0.157 | Folate antagonist | 0.157 0.02 DBMET00484 0.125 0.035 DBMET02241 | DBMET00484 | |
| 0.011 | 0.201 | 0.231 | Prostaglandin EP2 antagonist | 0.178 0.008 DBMET00484 0.231 0.005 DBMET02241 | DBMET02241 | |
| 0.048 | 0.239 | 0.122 | Alkaline phosphatase inhibitor | 0.122 0.083 DBMET00484 | DBMET00484 | |
| 0.003 | 0.2 | 0.055 | Carbonic anhydrase VIII inhibitor | 0.055 0.002 DBMET00484 0.03 0.004 DBMET00489 0.053 0.002 DBMET02241 | DBMET00484 | |
| 0.003 | 0.2 | 0.055 | Carbonic anhydrase X inhibitor | 0.055 0.002 DBMET00484 0.03 0.004 DBMET00489 0.053 0.002 DBMET02241 | DBMET00484 | |
| 0.015 | 0.214 | 0.05 | Sphingosine kinase 1 inhibitor | 0.044 0.024 DBMET00484 0.05 0.016 DBMET02241 | DBMET02241 | |
| 0.009 | 0.212 | 0.07 | Lysophosphatidic acid receptor 1 agonist | 0.054 0.004 DBMET00484 0.033 0.009 DBMET00489 0.07 0.003 DBMET02241 | DBMET02241 | |
| 0.02 | 0.231 | 0.114 | Carbonic anhydrase VA inhibitor | 0.114 0.02 DBMET00484 0.067 0.049 DBMET02241 | DBMET00484 | |
| 0.025 | 0.238 | 0.239 | Aminopeptidase I inhibitor | 0.22 0.005 DBMET00484 0.142 0.014 DBMET00489 0.239 0.005 DBMET02241 | DBMET02241 | |
| 0.003 | 0.216 | 0.077 | Neutral endopeptidase inhibitor | 0.019 0.017 DBMET00484 0.077 0.005 DBMET02241 | DBMET02241 | |
| 0.002 | 0.218 | 0.089 | Prostaglandin EP4 agonist | 0.034 0.006 DBMET00484 0.089 0.004 DBMET02241 | DBMET02241 | |
| 0.009 | 0.228 | 0.102 | ATP citrate lysase inhibitor | 0.06 0.005 DBMET00484 0.032 0.022 DBMET00489 0.102 0.003 DBMET02241 | DBMET02241 | |
| 0.021 | 0.24 | 0.064 | Sphingosine kinase 2 inhibitor | 0.058 0.034 DBMET00484 0.058 0.034 DBMET00489 0.064 0.027 DBMET02241 | DBMET02241 | |
| 0.115 | 0.335 | 0.218 | Antiobesity | 0.218 0.189 DBMET02241 | DBMET02241 | |
| 0.017 | 0.241 | 0.123 | Carbonic anhydrase V inhibitor | 0.123 0.021 DBMET00484 0.061 0.053 DBMET02241 | DBMET00484 | |
| 0.012 | 0.239 | 0.076 | Xanthine dehydrogenase inhibitor | 0.076 0.027 DBMET00484 0.07 0.031 DBMET02241 | DBMET00484 | |
| 0.054 | 0.281 | 0.179 | TRPA1 agonist | 0.179 0.016 DBMET00484 0.099 0.089 DBMET00489 0.156 0.027 DBMET02241 | DBMET00484 | |
| 0.014 | 0.246 | 0.054 | Prolyl endopeptidase inhibitor | 0.054 0.031 DBMET00484 | DBMET00484 | |
| 0.014 | 0.248 | 0.033 | Hedgehog signaling activator | 0.033 0.008 DBMET00484 0.032 0.009 DBMET00489 0.032 0.009 DBMET02241 | DBMET00484 | |
| 0.02 | 0.255 | 0.078 | Sphingosine kinase inhibitor | 0.07 0.025 DBMET00484 0.054 0.051 DBMET00489 0.078 0.018 DBMET02241 | DBMET02241 | |
| 0.019 | 0.254 | 0.669 | Porphobilinogen synthase inhibitor | 0.669 0.003 DBMET00484 0.301 0.005 DBMET00489 0.397 0.004 DBMET02241 | DBMET00484 | |
| 0.02 | 0.256 | 0.605 | Glutamate decarboxylase inhibitor | 0.605 0.002 DBMET00484 0.19 0.008 DBMET00489 0.473 0.003 DBMET02241 | DBMET00484 | |
| 0.033 | 0.27 | 0.312 | Creatine kinase inhibitor | 0.312 0.004 DBMET00484 0.214 0.009 DBMET00489 0.221 0.008 DBMET02241 | DBMET00484 | |
| 0.018 | 0.257 | 0.475 | Phenylalanine 4-hydroxylase inhibitor | 0.336 0.004 DBMET00484 0.167 0.01 DBMET00489 0.475 0.003 DBMET02241 | DBMET02241 | |
| 0.002 | 0.248 | 0.012 | Immunosuppressant Cyclosporine-like | 0.012 0.008 DBMET00484 | DBMET00484 | |
| 0.046 | 0.293 | 0.154 | Carbonic anhydrase XV inhibitor | 0.154 0.029 DBMET00484 0.131 0.039 DBMET00489 0.098 0.07 DBMET02241 | DBMET00484 | |
| 0.043 | 0.29 | 0.355 | Protein-tyrosine phosphatase inhibitor | 0.229 0.037 DBMET00484 0.355 0.012 DBMET02241 | DBMET02241 | |
| 0.006 | 0.261 | 0.064 | Prostaglandin D2 agonist | 0.055 0.006 DBMET00484 0.064 0.005 DBMET02241 | DBMET02241 | |
| 0.005 | 0.264 | 0.104 | Prostaglandin agonist | 0.056 0.009 DBMET00484 0.104 0.005 DBMET02241 | DBMET02241 | |
| 0.013 | 0.274 | 0.091 | Maillard reaction inhibitor | 0.091 0.02 DBMET00484 | DBMET00484 | |
| 0.029 | 0.289 | 0.257 | Aminopeptidase B inhibitor | 0.256 0.012 DBMET00484 0.181 0.026 DBMET00489 0.257 0.012 DBMET02241 | DBMET02241 | |
| 0.02 | 0.281 | 0.154 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.154 0.017 DBMET00484 0.078 0.053 DBMET00489 0.1 0.038 DBMET02241 | DBMET00484 | |
| 0.048 | 0.309 | 0.152 | Estrogen-related receptor beta agonist | 0.152 0.004 DBMET00484 0.109 0.016 DBMET00489 0.11 0.015 DBMET02241 | DBMET00484 | |
| 0.039 | 0.301 | 0.33 | Psychostimulant | 0.33 0.036 DBMET00484 0.263 0.054 DBMET02241 | DBMET00484 | |
| 0.024 | 0.287 | 0.087 | Protease 3C (Human rhinovirus) inhibitor | 0.087 0.022 DBMET00484 0.08 0.027 DBMET02241 | DBMET00484 | |
| 0.008 | 0.271 | 0.044 | Thyroid hormone agonist | 0.044 0.005 DBMET00484 0.03 0.013 DBMET02241 | DBMET00484 | |
| 0.002 | 0.265 | 0.026 | Aminopeptidase A inhibitor | 0.025 0.008 DBMET00484 0.026 0.008 DBMET02241 | DBMET02241 | |
| 0.004 | 0.268 | 0.035 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.035 0.014 DBMET00484 | DBMET00484 | |
| 0.088 | 0.352 | 0.257 | Transcription factor STAT3 inhibitor | 0.25 0.083 DBMET00484 0.257 0.078 DBMET02241 | DBMET02241 | |
| 0.017 | 0.284 | 0.083 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.083 0.004 DBMET00484 0.074 0.004 DBMET00489 0.059 0.008 DBMET02241 | DBMET00484 | |
| 0.02 | 0.288 | 0.123 | CDC25A inhibitor | 0.123 0.018 DBMET00484 | DBMET00484 | |
| 0.041 | 0.315 | 0.121 | Cyclooxygenase inhibitor | 0.121 0.097 DBMET00484 | DBMET00484 | |
| 0.008 | 0.283 | 0.102 | Carbonic anhydrase VB inhibitor | 0.102 0.016 DBMET00484 0.054 0.04 DBMET00489 0.062 0.034 DBMET02241 | DBMET00484 | |
| 0.034 | 0.31 | 0.145 | Cyclooxygenase 1 inhibitor | 0.145 0.059 DBMET00484 | DBMET00484 | |
| 0.011 | 0.289 | 0.125 | Membrane dipeptidase inhibitor | 0.125 0.003 DBMET00484 0.055 0.013 DBMET00489 0.084 0.005 DBMET02241 | DBMET00484 | |
| 0.026 | 0.305 | 0.118 | DNA helicase inhibitor | 0.118 0.004 DBMET00484 0.079 0.012 DBMET02241 | DBMET00484 | |
| 0.033 | 0.312 | 0.158 | Interleukin 1 beta converting enzyme inhibitor | 0.158 0.014 DBMET00484 0.112 0.043 DBMET02241 | DBMET00484 | |
| 0.04 | 0.324 | 0.157 | Granulocyte macrophage colony stimulating factor agonist | 0.157 0.005 DBMET00484 0.122 0.015 DBMET00489 0.119 0.017 DBMET02241 | DBMET00484 | |
| 0.038 | 0.322 | 0.092 | MAP kinase kinase 7 inhibitor | 0.092 0.021 DBMET00484 0.09 0.024 DBMET00489 0.083 0.038 DBMET02241 | DBMET00484 | |
| 0.007 | 0.292 | 0.026 | Caspase 8 inhibitor | 0.026 0.007 DBMET00484 0.021 0.012 DBMET02241 | DBMET00484 | |
| 0.021 | 0.309 | 0.102 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.102 0.012 DBMET00484 0.088 0.024 DBMET00489 0.078 0.041 DBMET02241 | DBMET00484 | |
| 0.003 | 0.295 | 0.063 | Prostaglandin E2 agonist | 0.033 0.009 DBMET00484 0.063 0.005 DBMET02241 | DBMET02241 | |
| 0.047 | 0.344 | 0.619 | Peroxidase inhibitor | 0.605 0.004 DBMET00484 0.476 0.012 DBMET00489 0.619 0.004 DBMET02241 | DBMET02241 | |
| 0.03 | 0.327 | 0.096 | Protein kinase C gamma inhibitor | 0.096 0.085 DBMET00484 | DBMET00484 | |
| 0.035 | 0.334 | 0.11 | Vanilloid 4 agonist | 0.11 0.011 DBMET00484 0.091 0.025 DBMET00489 0.11 0.011 DBMET02241 | DBMET02241 | |
| 0.027 | 0.328 | 0.086 | Ryanodine receptor antagonist | 0.086 0.006 DBMET00484 0.064 0.027 DBMET00489 0.069 0.019 DBMET02241 | DBMET00484 | |
| 0.029 | 0.333 | 0.112 | Caspase 9 inhibitor | 0.112 0.011 DBMET00484 0.073 0.028 DBMET02241 | DBMET00484 | |
| 0.019 | 0.324 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.035 DBMET00484 | DBMET00484 | |
| 0.029 | 0.334 | 0.26 | Keratolytic | 0.26 0.005 DBMET00484 0.105 0.028 DBMET00489 0.187 0.01 DBMET02241 | DBMET00484 | |
| 0.012 | 0.318 | 0.118 | Leukotriene antagonist | 0.089 0.027 DBMET00484 0.118 0.016 DBMET02241 | DBMET02241 | |
| 0.008 | 0.317 | 0.073 | Thymidylate synthase inhibitor | 0.073 0.01 DBMET00484 0.05 0.028 DBMET02241 | DBMET00484 | |
| 0.119 | 0.432 | 0.477 | 5 Hydroxytryptamine uptake stimulant | 0.477 0.005 DBMET00484 0.362 0.022 DBMET00489 0.397 0.015 DBMET02241 | DBMET00484 | |
| 0.012 | 0.324 | 0.104 | Lysophosphatidic acid 3 receptor antagonist | 0.099 0.005 DBMET00484 0.064 0.019 DBMET00489 0.104 0.004 DBMET02241 | DBMET02241 | |
| 0.004 | 0.321 | 0.069 | Lysine carboxypeptidase inhibitor | 0.06 0.006 DBMET00484 0.034 0.013 DBMET00489 0.069 0.005 DBMET02241 | DBMET02241 | |
| 0.007 | 0.324 | 0.095 | Dopamine D5 agonist | 0.095 0.004 DBMET00484 0.065 0.01 DBMET00489 0.047 0.02 DBMET02241 | DBMET00484 | |
| 0.015 | 0.341 | 0.082 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.075 0.019 DBMET00484 0.07 0.021 DBMET00489 0.082 0.015 DBMET02241 | DBMET02241 | |
| 0.015 | 0.345 | 0.057 | Carnitine palmitoyltransferase 1B inhibitor | 0.057 0.02 DBMET00484 | DBMET00484 | |
| 0.035 | 0.367 | 0.094 | mTOR complex 2 inhibitor | 0.094 0.041 DBMET00484 0.087 0.053 DBMET00489 0.082 0.064 DBMET02241 | DBMET00484 | |
| 0.015 | 0.347 | 0.048 | Potassium channel (ATP-sensitive) activator | 0.048 0.033 DBMET00484 | DBMET00484 | |
| 0.099 | 0.432 | 0.437 | Calcium channel activator | 0.437 0.014 DBMET00484 0.319 0.073 DBMET00489 0.392 0.028 DBMET02241 | DBMET00484 | |
| 0.016 | 0.352 | 0.051 | Potassium channel (Inward rectifier) activator | 0.051 0.034 DBMET00484 | DBMET00484 | |
| 0.072 | 0.409 | 0.244 | Transcription factor STAT inhibitor | 0.244 0.091 DBMET00484 0.229 0.103 DBMET02241 | DBMET00484 | |
| 0.009 | 0.346 | 0.036 | Estrogen-related receptor gamma antagonist | 0.036 0.008 DBMET00484 0.034 0.01 DBMET00489 | DBMET00484 | |
| 0.022 | 0.363 | 0.045 | Heme oxygenase inhibitor | 0.044 0.025 DBMET00484 0.043 0.029 DBMET00489 0.045 0.024 DBMET02241 | DBMET02241 | |
| 0.004 | 0.347 | 0.053 | Carbonic anhydrase IV inhibitor | 0.053 0.023 DBMET00484 0.042 0.03 DBMET02241 | DBMET00484 | |
| 0.019 | 0.364 | 0.097 | Pregnane X receptor antagonist | 0.097 0.004 DBMET00484 0.069 0.016 DBMET00489 0.071 0.013 DBMET02241 | DBMET00484 | |
| 0.005 | 0.352 | 0.06 | Purinergic P2Y antagonist | 0.06 0.019 DBMET00484 0.058 0.02 DBMET02241 | DBMET00484 | |
| 0.049 | 0.398 | 0.132 | Transcription factor STAT6 inhibitor | 0.132 0.042 DBMET00484 | DBMET00484 | |
| 0.003 | 0.354 | 0.092 | Kynurenine 3 monooxygenase inhibitor | 0.063 0.005 DBMET00484 0.092 0.004 DBMET02241 | DBMET02241 | |
| 0.027 | 0.378 | 0.247 | Chelator | 0.247 0.017 DBMET00484 0.159 0.032 DBMET02241 | DBMET00484 | |
| 0.013 | 0.367 | 0.09 | CDC25B inhibitor | 0.09 0.021 DBMET00484 | DBMET00484 | |
| 0.029 | 0.386 | 0.173 | Cytidine deaminase inhibitor | 0.173 0.06 DBMET00484 0.137 0.086 DBMET02241 | DBMET00484 | |
| 0.006 | 0.367 | 0.056 | HIV-1 protease inhibitor | 0.056 0.015 DBMET02241 | DBMET02241 | |
| 0.036 | 0.398 | 0.227 | DOPA decarboxylase inhibitor | 0.227 0.004 DBMET00484 0.172 0.012 DBMET00489 0.171 0.013 DBMET02241 | DBMET00484 | |
| 0.024 | 0.392 | 0.561 | Ferrochelatase inhibitor | 0.561 0.002 DBMET00484 0.392 0.004 DBMET00489 0.469 0.003 DBMET02241 | DBMET00484 | |
| 0.007 | 0.377 | 0.063 | Calcitonin receptor agonist | 0.045 0.018 DBMET00484 0.063 0.014 DBMET02241 | DBMET02241 | |
| 0.015 | 0.386 | 0.051 | Leukotriene C4 antagonist | 0.051 0.01 DBMET00484 0.046 0.014 DBMET02241 | DBMET00484 | |
| 0.001 | 0.374 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.006 DBMET00484 0.007 0.005 DBMET00489 | DBMET00489 | |
| 0.005 | 0.384 | 0.029 | 5-Alpha-reductase 2 inhibitor | 0.029 0.009 DBMET00484 | DBMET00484 | |
| 0.095 | 0.477 | 0.551 | Tyrosine 3 hydroxylase inhibitor | 0.551 0.003 DBMET00484 0.372 0.012 DBMET00489 0.408 0.007 DBMET02241 | DBMET00484 | |
| 0.001 | 0.388 | 0.025 | G-protein-coupled receptor 120 agonist | 0.025 0.006 DBMET00484 0.023 0.008 DBMET02241 | DBMET00484 | |
| 0.004 | 0.393 | 0.071 | Geranyltranstransferase inhibitor | 0.071 0.007 DBMET00484 0.058 0.015 DBMET00489 0.061 0.013 DBMET02241 | DBMET00484 | |
| 0.021 | 0.415 | 0.074 | Leukotriene C antagonist | 0.074 0.011 DBMET00484 0.055 0.042 DBMET00489 0.07 0.014 DBMET02241 | DBMET00484 | |
| 0.018 | 0.416 | 0.071 | Beta 2 adrenoreceptor agonist | 0.064 0.036 DBMET00484 0.071 0.018 DBMET00489 0.062 0.042 DBMET02241 | DBMET00489 | |
| 0.006 | 0.406 | 0.111 | Glutamate (mGluR3) antagonist | 0.111 0.004 DBMET00484 0.045 0.016 DBMET00489 0.08 0.005 DBMET02241 | DBMET00484 | |
| 0.004 | 0.408 | 0.115 | Peroxisome proliferator-activated receptor alpha agonist | 0.073 0.02 DBMET00484 0.115 0.01 DBMET02241 | DBMET02241 | |
| 0.006 | 0.411 | 0.08 | GABA uptake inhibitor | 0.08 0.005 DBMET00484 0.055 0.012 DBMET00489 0.062 0.009 DBMET02241 | DBMET00484 | |
| 0.005 | 0.412 | 0.041 | Retinoid X beta receptor antagonist | 0.041 0.003 DBMET00484 0.024 0.008 DBMET00489 0.028 0.005 DBMET02241 | DBMET00484 | |
| 0.001 | 0.411 | 0.021 | Carbonic anhydrase XI inhibitor | 0.021 0.004 DBMET00484 0.013 0.009 DBMET00489 0.018 0.005 DBMET02241 | DBMET00484 | |
| 0.02 | 0.431 | 0.337 | GABA C receptor antagonist | 0.337 0.004 DBMET00484 0.228 0.009 DBMET00489 0.291 0.005 DBMET02241 | DBMET00484 | |
| 0.036 | 0.452 | 0.131 | D-Ala-D-Ala ligase inhibitor | 0.131 0.009 DBMET00484 0.11 0.02 DBMET00489 0.109 0.021 DBMET02241 | DBMET00484 | |
| 0.024 | 0.441 | 0.272 | GABA C receptor rho-1 antagonist | 0.272 0.004 DBMET00484 0.199 0.008 DBMET00489 0.252 0.004 DBMET02241 | DBMET00484 | |
| 0.038 | 0.458 | 0.856 | Aldehyde oxidase inhibitor | 0.74 0.006 DBMET00484 0.579 0.022 DBMET00489 0.856 0.004 DBMET02241 | DBMET02241 | |
| 0.005 | 0.429 | 0.02 | CXC chemokine 5 receptor antagonist | 0.02 0.009 DBMET00484 | DBMET00484 | |
| 0.018 | 0.444 | 0.128 | Potassium channel (Ca-activated) activator | 0.128 0.037 DBMET00484 0.101 0.055 DBMET02241 | DBMET00484 | |
| 0.007 | 0.437 | 0.052 | Oxytocin agonist | 0.052 0.022 DBMET00484 0.046 0.027 DBMET00489 | DBMET00484 | |
| 0.006 | 0.439 | 0.039 | Integrin alpha2beta1 antagonist | 0.039 0.006 DBMET00484 0.026 0.02 DBMET00489 0.026 0.02 DBMET02241 | DBMET00484 | |
| 0.024 | 0.464 | 0.232 | HIV-1 integrase (Overall Integration) inhibitor | 0.232 0.006 DBMET00484 0.148 0.026 DBMET00489 0.164 0.021 DBMET02241 | DBMET00484 | |
| 0.003 | 0.448 | 0.103 | Retinoid X receptor agonist | 0.103 0.004 DBMET00484 0.036 0.024 DBMET00489 0.096 0.005 DBMET02241 | DBMET00484 | |
| 0.01 | 0.457 | 0.096 | Adenylate cyclase 1 inhibitor | 0.096 0.005 DBMET00484 0.061 0.017 DBMET00489 0.081 0.008 DBMET02241 | DBMET00484 | |
| 0.004 | 0.453 | 0.065 | Dihydropteroate synthase inhibitor | 0.065 0.01 DBMET00484 0.04 0.027 DBMET00489 | DBMET00484 | |
| 0.004 | 0.454 | 0.023 | Leukotriene B4 receptor 2 antagonist | 0.023 0.014 DBMET00484 0.02 0.019 DBMET02241 | DBMET00484 | |
| 0.003 | 0.455 | 0.025 | Estrogen-related receptor gamma agonist | 0.025 0.005 DBMET00484 | DBMET00484 | |
| 0.026 | 0.48 | 0.136 | Acetylcholine M1 receptor antagonist | 0.136 0.089 DBMET00484 | DBMET00484 | |
| 0.021 | 0.477 | 0.132 | Exportin-1 inhibitor | 0.122 0.004 DBMET00484 0.081 0.023 DBMET00489 0.132 0.004 DBMET02241 | DBMET02241 | |
| 0.062 | 0.521 | 0.245 | Neurotensin receptor agonist | 0.245 0.022 DBMET00484 0.166 0.069 DBMET00489 0.182 0.048 DBMET02241 | DBMET00484 | |
| 0.002 | 0.462 | 0.014 | Integrin alphaVbeta6 antagonist | 0.014 0.01 DBMET00484 0.013 0.011 DBMET02241 | DBMET00484 | |
| 0.004 | 0.465 | 0.123 | Retinoid X alpha receptor agonist | 0.123 0.004 DBMET00484 0.04 0.02 DBMET00489 0.074 0.008 DBMET02241 | DBMET00484 | |
| 0.019 | 0.485 | 0.227 | Prolactin inhibitor | 0.227 0.005 DBMET00484 0.133 0.03 DBMET00489 0.165 0.017 DBMET02241 | DBMET00484 | |
| 0.001 | 0.47 | 0.009 | Integrin alpha5beta6 antagonist | 0.009 0.003 DBMET00484 0.006 0.005 DBMET02241 | DBMET00484 | |
| 0.037 | 0.508 | 0.279 | GABA C receptor rho-2 antagonist | 0.279 0.007 DBMET00484 0.228 0.017 DBMET00489 0.199 0.029 DBMET02241 | DBMET00484 | |
| 0.001 | 0.474 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.018 0.005 DBMET00484 0.015 0.007 DBMET00489 | DBMET00484 | |
| 0.008 | 0.491 | 0.077 | Metalloproteinase-9 inhibitor | 0.069 0.058 DBMET00484 0.071 0.054 DBMET00489 0.077 0.046 DBMET02241 | DBMET02241 | |
| 0.018 | 0.502 | 0.168 | Caspase 3 inhibitor | 0.168 0.018 DBMET00484 0.13 0.046 DBMET02241 | DBMET00484 | |
| 0.029 | 0.513 | 0.138 | NADPH oxidase inhibitor | 0.138 0.064 DBMET00484 | DBMET00484 | |
| 0.031 | 0.517 | 0.084 | Calcium channel P-type blocker | 0.068 0.033 DBMET00484 0.063 0.047 DBMET00489 0.084 0.012 DBMET02241 | DBMET02241 | |
| 0.026 | 0.515 | 0.063 | Transcription factor RelA inhibitor | 0.063 0.046 DBMET00484 0.062 0.049 DBMET00489 | DBMET00484 | |
| 0.012 | 0.503 | 0.055 | Vanilloid 3 antagonist | 0.055 0.006 DBMET00484 0.037 0.031 DBMET00489 0.042 0.018 DBMET02241 | DBMET00484 | |
| 0.001 | 0.495 | 0.038 | Prostaglandin H2 antagonist | 0.038 0.007 DBMET00484 0.03 0.014 DBMET02241 | DBMET00484 | |
| 0.103 | 0.599 | 0.424 | Calcium channel L-type activator | 0.424 0.066 DBMET00484 0.284 0.171 DBMET02241 | DBMET00484 | |
| 0.017 | 0.516 | 0.079 | CD45 antagonist | 0.067 0.017 DBMET00484 0.079 0.012 DBMET02241 | DBMET02241 | |
| 0.003 | 0.504 | 0.044 | Nicotinic acid receptor 2 antagonist | 0.044 0.004 DBMET00484 0.035 0.008 DBMET00489 0.028 0.015 DBMET02241 | DBMET00484 | |
| 0.007 | 0.509 | 0.054 | Integrin alpha2 antagonist | 0.054 0.01 DBMET00484 0.035 0.029 DBMET00489 0.036 0.028 DBMET02241 | DBMET00484 | |
| 0.023 | 0.526 | 0.164 | Interleukin 8 antagonist | 0.164 0.026 DBMET00484 0.12 0.061 DBMET02241 | DBMET00484 | |
| 0.003 | 0.506 | 0.023 | Beta 1 adrenoreceptor agonist | 0.023 0.015 DBMET02241 | DBMET02241 | |
| 0.015 | 0.52 | 0.084 | Dihydroorotate oxidase inhibitor | 0.084 0.009 DBMET00484 0.08 0.011 DBMET00489 0.059 0.03 DBMET02241 | DBMET00484 | |
| 0.003 | 0.509 | 0.085 | Peroxisome proliferator-activated receptor delta agonist | 0.048 0.013 DBMET00484 0.085 0.007 DBMET02241 | DBMET02241 | |
| 0.064 | 0.571 | 0.592 | GABA C receptor rho-3 antagonist | 0.592 0.008 DBMET00484 0.528 0.019 DBMET00489 0.478 0.032 DBMET02241 | DBMET00484 | |
| 0.015 | 0.522 | 0.053 | Nicotinic alpha3beta2 receptor antagonist | 0.053 0.037 DBMET00484 | DBMET00484 | |
| 0.045 | 0.553 | 0.546 | Superoxide dismutase inhibitor | 0.546 0.009 DBMET00484 0.337 0.04 DBMET00489 0.472 0.016 DBMET02241 | DBMET00484 | |
| 0.003 | 0.512 | 0.067 | Free fatty acid receptor 1 antagonist | 0.067 0.005 DBMET00484 0.033 0.024 DBMET00489 0.043 0.013 DBMET02241 | DBMET00484 | |
| 0.005 | 0.515 | 0.531 | Macrophage elastase inhibitor | 0.066 0.016 DBMET00484 0.531 0.003 DBMET00489 0.075 0.013 DBMET02241 | DBMET00489 | |
| 0.012 | 0.522 | 0.126 | Glutamate (mGluR7) antagonist | 0.126 0.004 DBMET00484 0.098 0.012 DBMET00489 0.106 0.008 DBMET02241 | DBMET00484 | |
| 0.002 | 0.516 | 0.025 | Nicotinic acid receptor 1 antagonist | 0.025 0.005 DBMET00484 0.02 0.009 DBMET00489 | DBMET00484 | |
| 0.001 | 0.516 | 0.011 | Carboxypeptidase B2 inhibitor | 0.011 0.008 DBMET00484 0.011 0.007 DBMET02241 | DBMET02241 | |
| 0.001 | 0.524 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 DBMET00484 | DBMET00484 | |
| 0.017 | 0.543 | 0.089 | Somatostatin 1 agonist | 0.089 0.042 DBMET02241 | DBMET02241 | |
| 0.053 | 0.581 | 0.39 | Lipocortins synthesis antagonist | 0.39 0.009 DBMET00484 0.24 0.037 DBMET02241 | DBMET00484 | |
| 0.016 | 0.544 | 0.146 | GABA B receptor agonist | 0.146 0.004 DBMET00484 0.097 0.019 DBMET00489 0.138 0.005 DBMET02241 | DBMET00484 | |
| 0.033 | 0.561 | 0.409 | Cardiotonic | 0.275 0.067 DBMET00489 0.409 0.027 DBMET02241 | DBMET02241 | |
| 0.014 | 0.547 | 0.105 | Histamine N-methyltransferase inhibitor | 0.105 0.041 DBMET00484 0.087 0.059 DBMET00489 | DBMET00484 | |
| 0.013 | 0.548 | 0.061 | Transcription factor AP-1 inhibitor | 0.061 0.044 DBMET00484 | DBMET00484 | |
| 0.019 | 0.557 | 0.206 | Cathepsin H inhibitor | 0.183 0.028 DBMET00484 0.135 0.058 DBMET00489 0.206 0.021 DBMET02241 | DBMET02241 | |
| 0.008 | 0.553 | 0.059 | Retinoid X alpha receptor antagonist | 0.059 0.004 DBMET00484 0.038 0.018 DBMET00489 0.045 0.01 DBMET02241 | DBMET00484 | |
| 0.009 | 0.555 | 0.068 | Retinoid X receptor antagonist | 0.068 0.004 DBMET00484 0.042 0.02 DBMET00489 0.051 0.011 DBMET02241 | DBMET00484 | |
| 0.007 | 0.555 | 0.058 | HCV NS3/NS4A protease inhibitor | 0.058 0.023 DBMET00484 0.054 0.028 DBMET02241 | DBMET00484 | |
| 0.008 | 0.561 | 0.052 | Epithelial sodium channel blocker | 0.052 0.043 DBMET00484 0.051 0.048 DBMET02241 | DBMET00484 | |
| 0.004 | 0.559 | 0.078 | Thromboxane A2 antagonist | 0.078 0.016 DBMET00484 0.076 0.017 DBMET02241 | DBMET00484 | |
| 0.005 | 0.56 | 0.074 | Angiotensin-converting enzyme inhibitor | 0.074 0.017 DBMET00484 0.074 0.017 DBMET02241 | DBMET02241 | |
| 0.013 | 0.569 | 0.104 | Gastric antisecretory | 0.104 0.061 DBMET00484 0.087 0.082 DBMET02241 | DBMET00484 | |
| 0.003 | 0.56 | 0.033 | HCV NS5B polymerase inhibitor | 0.033 0.02 DBMET00484 | DBMET00484 | |
| 0.005 | 0.564 | 0.027 | ICAM 1 antagonist | 0.027 0.009 DBMET00484 0.025 0.012 DBMET02241 | DBMET00484 | |
| 0.021 | 0.582 | 0.187 | Antineoplastic alkaloid | 0.187 0.017 DBMET00484 | DBMET00484 | |
| 0.011 | 0.577 | 0.135 | Macrophage migration inhibitory factor inhibitor | 0.135 0.02 DBMET00484 0.071 0.064 DBMET02241 | DBMET00484 | |
| 0.005 | 0.571 | 0.045 | Carboxypeptidase B inhibitor | 0.044 0.01 DBMET00484 0.031 0.029 DBMET00489 0.045 0.009 DBMET02241 | DBMET02241 | |
| 0.001 | 0.568 | 0.013 | Integrin beta2 antagonist | 0.013 0.008 DBMET00484 | DBMET00484 | |
| 0.007 | 0.576 | 0.05 | Beta adrenoreceptor agonist | 0.043 0.041 DBMET00484 0.045 0.033 DBMET00489 0.05 0.017 DBMET02241 | DBMET02241 | |
| 0.004 | 0.575 | 0.034 | Retinoic acid receptor agonist | 0.034 0.008 DBMET00484 | DBMET00484 | |
| 0.002 | 0.574 | 0.031 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.031 0.024 DBMET00484 | DBMET00484 | |
| 0.007 | 0.581 | 0.084 | Metalloproteinase-2 inhibitor | 0.074 0.059 DBMET00484 0.084 0.049 DBMET02241 | DBMET02241 | |
| 0.002 | 0.576 | 0.113 | Glutamate (mGluR1a) agonist | 0.113 0.003 DBMET00484 0.035 0.007 DBMET00489 0.034 0.007 DBMET02241 | DBMET00484 | |
| 0.004 | 0.581 | 0.084 | Thromboxane antagonist | 0.084 0.018 DBMET00484 0.082 0.019 DBMET02241 | DBMET00484 | |
| 0.003 | 0.583 | 0.037 | Lysophosphatidic acid 1 receptor antagonist | 0.029 0.007 DBMET00484 0.037 0.005 DBMET02241 | DBMET02241 | |
| 0.015 | 0.597 | 0.063 | Bombesin 2 receptor antagonist | 0.058 0.025 DBMET00484 0.063 0.022 DBMET02241 | DBMET02241 | |
| 0.003 | 0.585 | 0.057 | Prostaglandin EP4 antagonist | 0.032 0.014 DBMET00484 0.057 0.007 DBMET02241 | DBMET02241 | |
| 0.011 | 0.594 | 0.189 | Aryl hydrocarbon receptor agonist | 0.189 0.108 DBMET00484 | DBMET00484 | |
| 0.003 | 0.587 | 0.055 | Farnesoid X receptor agonist | 0.049 0.015 DBMET00484 0.055 0.012 DBMET02241 | DBMET02241 | |
| 0.007 | 0.591 | 0.064 | Beta 2 adrenoreceptor antagonist | 0.051 0.034 DBMET00484 0.064 0.021 DBMET02241 | DBMET02241 | |
| 0.007 | 0.592 | 0.025 | Complement factor 1s inhibitor | 0.025 0.02 DBMET00484 0.024 0.022 DBMET00489 | DBMET00484 | |
| 0.006 | 0.593 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.02 DBMET00484 | DBMET00484 | |
| 0.004 | 0.592 | 0.05 | Liver X receptor alpha agonist | 0.05 0.019 DBMET00484 0.038 0.034 DBMET02241 | DBMET00484 | |
| 0.015 | 0.605 | 0.077 | Estrogen receptor alpha antagonist | 0.077 0.054 DBMET00484 | DBMET00484 | |
| 0.003 | 0.594 | 0.068 | Aromatase inhibitor | 0.068 0.036 DBMET00489 | DBMET00489 | |
| 0.002 | 0.593 | 0.011 | Retinoic acid receptor gamma antagonist | 0.011 0.009 DBMET00484 | DBMET00484 | |
| 0.002 | 0.594 | 0.043 | G protein-coupled receptor agonist | 0.033 0.031 DBMET00484 0.043 0.022 DBMET02241 | DBMET02241 | |
| 0.012 | 0.604 | 0.148 | Protease inhibitor | 0.148 0.03 DBMET02241 | DBMET02241 | |
| 0.001 | 0.598 | 0.026 | 5-Alpha-reductase 1 inhibitor | 0.026 0.009 DBMET00484 | DBMET00484 | |
| 0.004 | 0.602 | 0.061 | GABA B receptor antagonist | 0.058 0.014 DBMET00484 0.061 0.012 DBMET02241 | DBMET02241 | |
| 0.005 | 0.608 | 0.042 | Plasmepsin I inhibitor | 0.042 0.011 DBMET02241 | DBMET02241 | |
| 0.009 | 0.612 | 0.133 | Calcium antagonist | 0.127 0.031 DBMET00484 0.133 0.029 DBMET02241 | DBMET02241 | |
| 0.01 | 0.614 | 0.096 | Caspase 7 inhibitor | 0.096 0.033 DBMET00484 | DBMET00484 | |
| 0.001 | 0.614 | 0.056 | Peroxisome proliferator-activated receptor alpha antagonist | 0.03 0.012 DBMET00484 0.056 0.008 DBMET02241 | DBMET02241 | |
| 0.017 | 0.631 | 0.294 | Electrolyte absorption antagonist | 0.294 0.004 DBMET00484 0.154 0.018 DBMET00489 0.241 0.005 DBMET02241 | DBMET00484 | |
| 0.006 | 0.622 | 0.123 | Beta adrenoreceptor antagonist | 0.071 0.037 DBMET00484 0.123 0.01 DBMET02241 | DBMET02241 | |
| 0.003 | 0.619 | 0.038 | Carnitine palmitoyltransferase 1 inhibitor | 0.038 0.018 DBMET00484 | DBMET00484 | |
| 0.08 | 0.697 | 0.215 | 5 Hydroxytryptamine 3E antagonist | 0.211 0.047 DBMET00484 0.215 0.042 DBMET00489 0.172 0.129 DBMET02241 | DBMET00489 | |
| 0.007 | 0.625 | 0.205 | NMDA receptor agonist | 0.205 0.004 DBMET00484 0.084 0.027 DBMET00489 0.15 0.008 DBMET02241 | DBMET00484 | |
| 0.008 | 0.626 | 0.067 | Dopamine beta hydroxylase inhibitor | 0.067 0.009 DBMET00484 0.053 0.025 DBMET00489 0.05 0.031 DBMET02241 | DBMET00484 | |
| 0.003 | 0.623 | 0.038 | Carnitine palmitoyltransferase inhibitor | 0.038 0.018 DBMET00484 | DBMET00484 | |
| 0.024 | 0.648 | 0.132 | Glutamate (mGluR7) agonist | 0.132 0.021 DBMET00484 0.104 0.053 DBMET00489 0.103 0.054 DBMET02241 | DBMET00484 | |
| 0.003 | 0.628 | 0.061 | Potassium channel Kv1.3 blocker | 0.061 0.02 DBMET00484 | DBMET00484 | |
| 0.002 | 0.63 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.03 0.008 DBMET00484 | DBMET00484 | |
| 0.016 | 0.645 | 0.101 | MDM2 inhibitor | 0.099 0.007 DBMET00484 0.067 0.047 DBMET00489 0.101 0.007 DBMET02241 | DBMET02241 | |
| 0.005 | 0.635 | 0.082 | Beta 1 adrenoreceptor antagonist | 0.059 0.037 DBMET00484 0.082 0.017 DBMET02241 | DBMET02241 | |
| 0.011 | 0.643 | 0.102 | Beta 3 adrenoreceptor antagonist | 0.066 0.041 DBMET00484 0.102 0.014 DBMET02241 | DBMET02241 | |
| 0.004 | 0.637 | 0.042 | RNA-directed RNA polymerase inhibitor | 0.042 0.017 DBMET00484 | DBMET00484 | |
| 0.001 | 0.639 | 0.01 | Beta 3 adrenoreceptor agonist | 0.01 0.009 DBMET02241 | DBMET02241 | |
| 0.034 | 0.675 | 0.125 | MAP kinase 3 inhibitor | 0.125 0.12 DBMET00484 | DBMET00484 | |
| 0.003 | 0.645 | 0.044 | Alpha 1d adrenoreceptor agonist | 0.042 0.023 DBMET00484 0.044 0.021 DBMET00489 | DBMET00489 | |
| 0.003 | 0.648 | 0.153 | NMDA receptor glycine site agonist | 0.153 0.004 DBMET00484 0.085 0.025 DBMET00489 0.128 0.007 DBMET02241 | DBMET00484 | |
| 0.006 | 0.65 | 0.034 | Melatonin receptor 1A agonist | 0.034 0.022 DBMET00484 | DBMET00484 | |
| 0.003 | 0.648 | 0.042 | Leukotriene B4 receptor 1 antagonist | 0.041 0.011 DBMET00484 0.042 0.011 DBMET02241 | DBMET02241 | |
| 0.007 | 0.653 | 0.081 | CYP2A6 inhibitor | 0.081 0.047 DBMET00484 0.071 0.057 DBMET02241 | DBMET00484 | |
| 0.082 | 0.729 | 0.492 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.492 0.037 DBMET00484 0.469 0.049 DBMET00489 0.411 0.091 DBMET02241 | DBMET00484 | |
| 0.001 | 0.648 | 0.012 | Angiotensin AT2 receptor agonist | 0.012 0.006 DBMET00489 | DBMET00489 | |
| 0.007 | 0.656 | 0.118 | Carbonic anhydrase stimulant | 0.118 0.015 DBMET00484 0.064 0.037 DBMET00489 0.087 0.023 DBMET02241 | DBMET00484 | |
| 0.01 | 0.66 | 0.151 | Cathepsin G inhibitor | 0.151 0.021 DBMET00484 0.128 0.025 DBMET02241 | DBMET00484 | |
| 0.006 | 0.659 | 0.197 | Anesthetic local | 0.142 0.053 DBMET00484 0.197 0.033 DBMET00489 0.155 0.047 DBMET02241 | DBMET00489 | |
| 0.002 | 0.659 | 0.04 | Glutamate (mGluR group II) antagonist | 0.04 0.024 DBMET00484 | DBMET00484 | |
| 0.001 | 0.658 | 0.016 | Egl nine homolog 3 inhibitor | 0.016 0.005 DBMET00484 | DBMET00484 | |
| 0.013 | 0.675 | 0.246 | Bone formation stimulant | 0.246 0.025 DBMET00484 0.228 0.029 DBMET02241 | DBMET00484 | |
| 0.017 | 0.679 | 0.074 | Immunoglobulin Fc receptor antagonist | 0.064 0.017 DBMET00484 0.06 0.024 DBMET00489 0.074 0.009 DBMET02241 | DBMET02241 | |
| 0.003 | 0.667 | 0.05 | Liver X receptor beta antagonist | 0.05 0.008 DBMET00484 | DBMET00484 | |
| 0.009 | 0.674 | 0.132 | Falcipain 3 inhibitor | 0.132 0.046 DBMET00484 0.099 0.071 DBMET00489 0.099 0.071 DBMET02241 | DBMET00484 | |
| 0.042 | 0.709 | 0.419 | Sodium/bile acid cotransporter inhibitor | 0.419 0.012 DBMET00484 0.405 0.016 DBMET02241 | DBMET00484 | |
| 0.002 | 0.67 | 0.081 | Urate transporter 1 inhibitor | 0.081 0.008 DBMET00484 0.043 0.023 DBMET02241 | DBMET00484 | |
| 0.003 | 0.674 | 0.054 | Nerve growth factor antagonist | 0.054 0.014 DBMET00484 0.049 0.02 DBMET00489 | DBMET00484 | |
| 0.005 | 0.676 | 0.095 | Glutamate (mGluR1) agonist | 0.082 0.004 DBMET00484 0.026 0.014 DBMET00489 0.095 0.004 DBMET02241 | DBMET02241 | |
| 0.003 | 0.674 | 0.063 | Lysophosphatidic acid 2 receptor antagonist | 0.063 0.006 DBMET00484 0.058 0.007 DBMET02241 | DBMET00484 | |
| 0.001 | 0.677 | 0.034 | NMDA receptor glycine site antagonist | 0.034 0.011 DBMET00484 | DBMET00484 | |
| 0.003 | 0.679 | 0.052 | Cholesterol ester transfer protein antagonist | 0.034 0.018 DBMET00484 0.052 0.006 DBMET02241 | DBMET02241 | |
| 0.005 | 0.689 | 0.113 | Inducible nitric-oxide synthase inhibitor | 0.113 0.028 DBMET00484 | DBMET00484 | |
| 0.015 | 0.702 | 0.183 | Sphingosine 1-phosphate receptor 4 antagonist | 0.178 0.015 DBMET00484 0.119 0.074 DBMET00489 0.183 0.014 DBMET02241 | DBMET02241 | |
| 0.008 | 0.699 | 0.082 | Botulinum neurotoxin type A inhibitor | 0.075 0.02 DBMET00484 0.082 0.016 DBMET02241 | DBMET02241 | |
| 0.006 | 0.698 | 0.111 | Peroxisome proliferator-activated receptor gamma antagonist | 0.092 0.021 DBMET00484 0.111 0.011 DBMET02241 | DBMET02241 | |
| 0.005 | 0.702 | 0.057 | Tryptophan 5 hydroxylase inhibitor | 0.057 0.004 DBMET00484 0.038 0.019 DBMET00489 0.048 0.006 DBMET02241 | DBMET00484 | |
| 0.003 | 0.702 | 0.046 | Metalloproteinase-3 inhibitor | 0.046 0.037 DBMET00484 0.044 0.04 DBMET02241 | DBMET00484 | |
| 0.002 | 0.703 | 0.035 | Liver X receptor beta agonist | 0.035 0.02 DBMET00484 | DBMET00484 | |
| 0.004 | 0.706 | 0.033 | Protein kinase (CK2) beta inhibitor | 0.033 0.024 DBMET00484 0.031 0.03 DBMET00489 | DBMET00484 | |
| 0.004 | 0.706 | 0.626 | Peroxisome proliferator-activated receptor gamma agonist | 0.194 0.007 DBMET00484 0.626 0.003 DBMET02241 | DBMET02241 | |
| 0.004 | 0.707 | 0.15 | Sphingosine 1-phosphate receptor 4 agonist | 0.15 0.008 DBMET00484 0.069 0.045 DBMET00489 0.144 0.009 DBMET02241 | DBMET00484 | |
| 0.003 | 0.707 | 0.084 | Acetylcholine M5 receptor agonist | 0.084 0.031 DBMET00484 | DBMET00484 | |
| 0.015 | 0.721 | 0.23 | Antipruritic | 0.16 0.083 DBMET00484 0.23 0.032 DBMET02241 | DBMET02241 | |
| 0.001 | 0.708 | 0.043 | Kainate receptor 1 antagonist | 0.043 0.006 DBMET00484 | DBMET00484 | |
| 0.012 | 0.719 | 0.166 | Pregnane X receptor agonist | 0.166 0.03 DBMET00484 0.13 0.101 DBMET00489 0.132 0.094 DBMET02241 | DBMET00484 | |
| 0.008 | 0.717 | 0.082 | Myeloperoxidase inhibitor | 0.082 0.063 DBMET00484 | DBMET00484 | |
| 0.003 | 0.712 | 0.038 | LFA antagonist | 0.038 0.009 DBMET00484 0.03 0.016 DBMET02241 | DBMET00484 | |
| 0.004 | 0.714 | 0.063 | Dihydroorotase inhibitor | 0.063 0.014 DBMET00484 0.045 0.03 DBMET00489 | DBMET00484 | |
| 0.002 | 0.712 | 0.063 | Fructose-1,6-bisphosphatase inhibitor | 0.063 0.016 DBMET00484 | DBMET00484 | |
| 0.005 | 0.716 | 0.083 | Diacylglycerol O-acyltransferase inhibitor | 0.083 0.013 DBMET00484 0.058 0.027 DBMET02241 | DBMET00484 | |
| 0.004 | 0.717 | 0.075 | Thromboxane synthase inhibitor | 0.075 0.014 DBMET00484 0.072 0.016 DBMET02241 | DBMET00484 | |
| 0.002 | 0.716 | 0.072 | NMDA receptor subunit 3B antagonist | 0.072 0.015 DBMET00484 0.042 0.032 DBMET02241 | DBMET00484 | |
| 0.003 | 0.717 | 0.033 | Peptide deformylase inhibitor | 0.033 0.018 DBMET00484 | DBMET00484 | |
| 0.006 | 0.729 | 0.106 | Urease inhibitor | 0.106 0.061 DBMET00484 | DBMET00484 | |
| 0.003 | 0.726 | 0.064 | Matrix metalloproteinase inhibitor | 0.059 0.055 DBMET00484 0.063 0.05 DBMET00489 0.064 0.05 DBMET02241 | DBMET02241 | |
| 0.003 | 0.727 | 0.076 | Neutrophil collagenase inhibitor | 0.065 0.045 DBMET00484 0.076 0.035 DBMET00489 0.061 0.049 DBMET02241 | DBMET00489 | |
| 0.003 | 0.729 | 0.058 | Matrix metalloproteinase (membrane-type) inhibitor | 0.053 0.041 DBMET00484 0.058 0.034 DBMET00489 0.055 0.038 DBMET02241 | DBMET00489 | |
| 0.012 | 0.74 | 0.105 | Nav1.2 sodium channel blocker | 0.105 0.103 DBMET02241 | DBMET02241 | |
| 0.004 | 0.733 | 0.045 | Glutamate (mGluR4) agonist | 0.045 0.013 DBMET00484 | DBMET00484 | |
| 0.002 | 0.732 | 0.071 | NMDA receptor subunit 3A antagonist | 0.071 0.014 DBMET00484 0.034 0.03 DBMET02241 | DBMET00484 | |
| 0.004 | 0.734 | 0.074 | Nicotinic alpha4beta2 receptor antagonist | 0.074 0.057 DBMET00484 | DBMET00484 | |
| 0.011 | 0.747 | 0.127 | Proteasome inhibitor | 0.127 0.06 DBMET00484 0.111 0.073 DBMET02241 | DBMET00484 | |
| 0.001 | 0.738 | 0.018 | Angiotensin AT1B receptor antagonist | 0.018 0.007 DBMET00484 | DBMET00484 | |
| 0.003 | 0.741 | 0.067 | Nicotinic acid receptor agonist | 0.067 0.009 DBMET00484 0.043 0.018 DBMET02241 | DBMET00484 | |
| 0.003 | 0.743 | 0.042 | Histamine H2 receptor agonist | 0.042 0.031 DBMET00484 0.039 0.036 DBMET00489 | DBMET00484 | |
| 0.002 | 0.742 | 0.036 | Epoxide hydrolase 1 inhibitor | 0.036 0.015 DBMET00484 | DBMET00484 | |
| 0.004 | 0.746 | 0.089 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.019 DBMET00484 0.089 0.012 DBMET02241 | DBMET02241 | |
| 0.007 | 0.75 | 0.065 | Aldosterone antagonist | 0.054 0.024 DBMET00484 0.065 0.017 DBMET02241 | DBMET02241 | |
| 0.005 | 0.748 | 0.097 | Androgen antagonist | 0.097 0.049 DBMET00484 0.086 0.058 DBMET02241 | DBMET00484 | |
| 0.02 | 0.769 | 0.142 | Tumour necrosis factor antagonist | 0.142 0.11 DBMET00484 | DBMET00484 | |
| 0.005 | 0.755 | 0.129 | HIV-1 integrase inhibitor | 0.129 0.012 DBMET00484 0.113 0.018 DBMET02241 | DBMET00484 | |
| 0.005 | 0.756 | 0.211 | Calpain inhibitor | 0.211 0.103 DBMET00484 | DBMET00484 | |
| 0.003 | 0.756 | 0.086 | AMPA 4 receptor antagonist | 0.086 0.006 DBMET00484 0.037 0.032 DBMET00489 0.042 0.023 DBMET02241 | DBMET00484 | |
| 0.002 | 0.756 | 0.045 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.045 0.012 DBMET00484 0.045 0.012 DBMET02241 | DBMET02241 | |
| 0.002 | 0.757 | 0.024 | Retinoic acid receptor antagonist | 0.024 0.008 DBMET00484 | DBMET00484 | |
| 0.01 | 0.767 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | 0.059 0.048 DBMET00484 | DBMET00484 | |
| 0.003 | 0.762 | 0.045 | Angiotensin II receptor antagonist | 0.045 0.01 DBMET00484 0.039 0.016 DBMET02241 | DBMET00484 | |
| 0.002 | 0.762 | 0.035 | Methionyl aminopeptidase 2 inhibitor | 0.023 0.02 DBMET00484 0.035 0.011 DBMET02241 | DBMET02241 | |
| 0.007 | 0.768 | 0.107 | Glutamate (mGluR4) antagonist | 0.107 0.005 DBMET00484 0.047 0.024 DBMET00489 0.05 0.021 DBMET02241 | DBMET00484 | |
| 0.001 | 0.762 | 0.017 | Complement factor D inhibitor | 0.017 0.015 DBMET00484 | DBMET00484 | |
| 0.004 | 0.769 | 0.08 | Sphingosine 1-phosphate receptor 1 antagonist | 0.064 0.023 DBMET00484 0.08 0.014 DBMET02241 | DBMET02241 | |
| 0.005 | 0.77 | 0.104 | Glutamate (mGluR group III) antagonist | 0.104 0.005 DBMET00484 0.045 0.028 DBMET00489 0.054 0.017 DBMET02241 | DBMET00484 | |
| 0.003 | 0.769 | 0.064 | Leukotriene D4 antagonist | 0.026 0.019 DBMET00484 0.064 0.008 DBMET02241 | DBMET02241 | |
| 0.002 | 0.77 | 0.056 | Angiotensin AT1 receptor antagonist | 0.056 0.01 DBMET00484 0.051 0.016 DBMET02241 | DBMET00484 | |
| 0.001 | 0.77 | 0.084 | Kainate receptor 2 antagonist | 0.084 0.006 DBMET00484 0.035 0.025 DBMET02241 | DBMET00484 | |
| 0.001 | 0.771 | 0.015 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.015 0.009 DBMET00484 0.014 0.01 DBMET02241 | DBMET00484 | |
| 0.001 | 0.773 | 0.042 | Methionyl aminopeptidase 1 inhibitor | 0.042 0.01 DBMET00484 0.041 0.011 DBMET02241 | DBMET00484 | |
| 0.006 | 0.778 | 0.075 | Potassium channel (Tandem pore domain) blocker | 0.075 0.049 DBMET00484 0.07 0.062 DBMET02241 | DBMET00484 | |
| 0.006 | 0.778 | 0.072 | Calcium channel L-type blocker | 0.072 0.049 DBMET00484 | DBMET00484 | |
| 0.007 | 0.78 | 0.123 | 5 Hydroxytryptamine 3A agonist | 0.102 0.074 DBMET00484 0.123 0.053 DBMET00489 | DBMET00489 | |
| 0.002 | 0.775 | 0.029 | Calcium-sensing receptor agonist | 0.029 0.015 DBMET00484 | DBMET00484 | |
| 0.001 | 0.779 | 0.017 | Egl nine homolog 1 inhibitor | 0.017 0.008 DBMET00484 | DBMET00484 | |
| 0.004 | 0.782 | 0.104 | Adrenaline agonist | 0.076 0.063 DBMET00489 0.104 0.034 DBMET02241 | DBMET02241 | |
| 0.001 | 0.782 | 0.02 | Protease (Human cytomegalovirus) inhibitor | 0.02 0.018 DBMET00484 | DBMET00484 | |
| 0.003 | 0.787 | 0.049 | Glycine transporter 2 inhibitor | 0.049 0.031 DBMET00484 | DBMET00484 | |
| 0.005 | 0.79 | 0.081 | Glutamate (mGluR group III) agonist | 0.081 0.013 DBMET00484 | DBMET00484 | |
| 0.005 | 0.792 | 0.245 | Lipoxygenase inhibitor | 0.245 0.103 DBMET00484 | DBMET00484 | |
| 0.025 | 0.813 | 0.086 | CC chemokine 5 receptor agonist | 0.086 0.047 DBMET00484 0.083 0.054 DBMET00489 | DBMET00484 | |
| 0.002 | 0.79 | 0.063 | NMDA 2A receptor antagonist | 0.063 0.028 DBMET00484 0.055 0.033 DBMET02241 | DBMET00484 | |
| 0.002 | 0.791 | 0.086 | Sphingosine 1-phosphate receptor 1 agonist | 0.057 0.014 DBMET00484 0.086 0.005 DBMET02241 | DBMET02241 | |
| 0.002 | 0.792 | 0.049 | AMPA 3 receptor antagonist | 0.049 0.009 DBMET00484 0.03 0.02 DBMET02241 | DBMET00484 | |
| 0.001 | 0.792 | 0.025 | CXC chemokine 2 receptor antagonist | 0.025 0.02 DBMET00484 | DBMET00484 | |
| 0.005 | 0.797 | 0.062 | Heat shock protein 90 beta antagonist | 0.062 0.037 DBMET00484 | DBMET00484 | |
| 0.006 | 0.798 | 0.214 | 12-Lipoxygenase inhibitor | 0.214 0.136 DBMET00484 | DBMET00484 | |
| 0.033 | 0.827 | 0.169 | Catenin beta inhibitor | 0.169 0.068 DBMET00484 0.159 0.086 DBMET02241 | DBMET00484 | |
| 0.015 | 0.81 | 0.181 | 3C-like protease (Human coronavirus) inhibitor | 0.178 0.067 DBMET00484 0.143 0.114 DBMET00489 0.181 0.064 DBMET02241 | DBMET02241 | |
| 0.001 | 0.797 | 0.076 | Kainate receptor antagonist | 0.076 0.011 DBMET00484 0.044 0.025 DBMET02241 | DBMET00484 | |
| 0.002 | 0.8 | 0.085 | Benzodiazepine agonist | 0.085 0.035 DBMET00489 | DBMET00489 | |
| 0.004 | 0.802 | 0.043 | MAP3K5 inhibitor | 0.043 0.021 DBMET00484 | DBMET00484 | |
| 0.002 | 0.801 | 0.086 | NMDA 2C receptor antagonist | 0.086 0.021 DBMET00484 | DBMET00484 | |
| 0.004 | 0.806 | 0.032 | Caspase 6 inhibitor | 0.032 0.017 DBMET00484 | DBMET00484 | |
| 0.004 | 0.806 | 0.217 | Calpain 2 inhibitor | 0.217 0.173 DBMET00484 | DBMET00484 | |
| 0.004 | 0.808 | 0.109 | Nitric-oxide synthase inhibitor | 0.109 0.047 DBMET00484 | DBMET00484 | |
| 0.009 | 0.813 | 0.073 | Glutamate (mGluR8) antagonist | 0.073 0.004 DBMET00484 0.05 0.009 DBMET02241 | DBMET00484 | |
| 0.003 | 0.807 | 0.088 | NMDA receptor antagonist | 0.088 0.056 DBMET00484 0.079 0.067 DBMET02241 | DBMET00484 | |
| 0.003 | 0.808 | 0.048 | Benzodiazepine antagonist | 0.048 0.032 DBMET00484 | DBMET00484 | |
| 0.004 | 0.811 | 0.19 | Sphingosine 1-phosphate receptor 2 antagonist | 0.19 0.01 DBMET00484 0.138 0.059 DBMET00489 0.182 0.014 DBMET02241 | DBMET00484 | |
| 0.004 | 0.811 | 0.103 | Glucagon-like peptide 1 agonist | 0.075 0.038 DBMET00484 0.103 0.02 DBMET02241 | DBMET02241 | |
| 0.004 | 0.818 | 0.103 | MAP kinase kinase 1 inhibitor | 0.088 0.073 DBMET00484 0.103 0.052 DBMET02241 | DBMET02241 | |
| 0.001 | 0.815 | 0.041 | AMPA 1 receptor antagonist | 0.041 0.014 DBMET00484 | DBMET00484 | |
| 0.005 | 0.819 | 0.128 | Leukotriene synthesis inhibitor | 0.128 0.014 DBMET00484 0.084 0.035 DBMET02241 | DBMET00484 | |
| 0.001 | 0.816 | 0.065 | Glucagon receptor antagonist | 0.039 0.014 DBMET00484 0.065 0.007 DBMET02241 | DBMET02241 | |
| 0.004 | 0.821 | 0.064 | Potassium channel intermediate-conductance Ca-activated blocker | 0.064 0.035 DBMET00484 | DBMET00484 | |
| 0.016 | 0.832 | 0.344 | Insulysin inhibitor | 0.344 0.036 DBMET00484 0.266 0.083 DBMET00489 0.318 0.049 DBMET02241 | DBMET00484 | |
| 0.009 | 0.828 | 0.186 | Thyroid hormone antagonist | 0.186 0.174 DBMET00484 | DBMET00484 | |
| 0.002 | 0.821 | 0.047 | Dihydrofolate reductase inhibitor | 0.047 0.023 DBMET00484 | DBMET00484 | |
| 0.007 | 0.829 | 0.171 | Prostaglandin F2 alpha antagonist | 0.092 0.015 DBMET00484 0.171 0.004 DBMET02241 | DBMET02241 | |
| 0.003 | 0.826 | 0.048 | Glutamate (mGluR1a) antagonist | 0.041 0.028 DBMET00484 0.048 0.022 DBMET02241 | DBMET02241 | |
| 0.004 | 0.829 | 0.102 | GABA A receptor agonist | 0.102 0.035 DBMET00489 | DBMET00489 | |
| 0.007 | 0.835 | 0.232 | 15-Lipoxygenase inhibitor | 0.232 0.18 DBMET00484 | DBMET00484 | |
| 0.029 | 0.858 | 0.416 | Growth hormone agonist | 0.416 0.014 DBMET00484 0.335 0.026 DBMET02241 | DBMET00484 | |
| 0.004 | 0.834 | 0.157 | GABA receptor agonist | 0.119 0.058 DBMET00484 0.157 0.032 DBMET00489 | DBMET00489 | |
| 0.007 | 0.841 | 0.21 | Sphingosine 1-phosphate receptor 5 antagonist | 0.21 0.008 DBMET00484 0.156 0.051 DBMET00489 0.178 0.026 DBMET02241 | DBMET00484 | |
| 0.001 | 0.836 | 0.031 | Aminopeptidase P inhibitor | 0.031 0.009 DBMET02241 | DBMET02241 | |
| 0.002 | 0.837 | 0.101 | Sphingosine 1-phosphate receptor agonist | 0.059 0.017 DBMET00484 0.101 0.005 DBMET02241 | DBMET02241 | |
| 0.006 | 0.842 | 0.124 | Nav1.6 sodium channel blocker | 0.112 0.109 DBMET00484 0.124 0.09 DBMET02241 | DBMET02241 | |
| 0.002 | 0.842 | 0.067 | Leukocyte elastase inhibitor | 0.067 0.015 DBMET00484 0.057 0.019 DBMET00489 0.038 0.037 DBMET02241 | DBMET00484 | |
| 0.013 | 0.854 | 0.147 | Histone acetyltransferase inhibitor | 0.147 0.144 DBMET00484 | DBMET00484 | |
| 0.003 | 0.845 | 0.072 | Secretase beta inhibitor | 0.072 0.046 DBMET02241 | DBMET02241 | |
| 0.007 | 0.855 | 0.046 | Elastase 3A inhibitor | 0.046 0.005 DBMET00484 | DBMET00484 | |
| 0.007 | 0.855 | 0.046 | Elastase 3B inhibitor | 0.046 0.005 DBMET00484 | DBMET00484 | |
| 0.007 | 0.855 | 0.046 | Elastase 2B inhibitor | 0.046 0.005 DBMET00484 | DBMET00484 | |
| 0.002 | 0.853 | 0.075 | Prostaglandin-E synthase inhibitor | 0.075 0.043 DBMET00484 | DBMET00484 | |
| 0.004 | 0.856 | 0.092 | Sphingosine 1-phosphate receptor antagonist | 0.087 0.034 DBMET00484 0.092 0.028 DBMET02241 | DBMET02241 | |
| 0.003 | 0.856 | 0.075 | Collagenase 3 inhibitor | 0.056 0.046 DBMET00484 0.075 0.028 DBMET00489 0.056 0.047 DBMET02241 | DBMET00489 | |
| 0.002 | 0.858 | 0.042 | Glutamate (mGluR group I) agonist | 0.042 0.04 DBMET00484 | DBMET00484 | |
| 0.003 | 0.862 | 0.209 | Prostaglandin dehydrogenase inhibitor | 0.209 0.151 DBMET00489 | DBMET00489 | |
| 0.004 | 0.865 | 0.212 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.212 0.093 DBMET00484 | DBMET00484 | |
| 0.012 | 0.873 | 0.232 | Neuropeptide Y2 antagonist | 0.211 0.101 DBMET00484 0.232 0.074 DBMET02241 | DBMET02241 | |
| 0.005 | 0.872 | 0.164 | Dual specificity phosphatase 3 inhibitor | 0.164 0.085 DBMET00484 | DBMET00484 | |
| 0.01 | 0.894 | 0.113 | Nav1.3 sodium channel blocker | 0.113 0.082 DBMET02241 | DBMET02241 | |
| 0.004 | 0.888 | 0.063 | Retinoic acid alpha receptor agonist | 0.063 0.008 DBMET00484 0.042 0.023 DBMET02241 | DBMET00484 | |
| 0.001 | 0.889 | 0.027 | Retinoic acid alpha receptor antagonist | 0.027 0.008 DBMET00484 | DBMET00484 | |
| 0.009 | 0.898 | 0.17 | Farnesoid X receptor antagonist | 0.17 0.035 DBMET00484 | DBMET00484 | |
| 0.005 | 0.896 | 0.15 | Thiol protease inhibitor | 0.15 0.068 DBMET00484 0.136 0.087 DBMET02241 | DBMET00484 | |
| 0.001 | 0.893 | 0.05 | AMPA receptor antagonist | 0.05 0.031 DBMET00484 | DBMET00484 | |
| 0.004 | 0.905 | 0.052 | VCAM-1 antagonist | 0.052 0.008 DBMET00484 0.038 0.032 DBMET02241 | DBMET00484 | |
| 0.004 | 0.905 | 0.052 | VCAM antagonist | 0.052 0.008 DBMET00484 0.038 0.032 DBMET02241 | DBMET00484 | |
| 0.008 | 0.91 | 0.033 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.029 DBMET00484 | DBMET00484 | |
| 0.002 | 0.905 | 0.023 | Calcium-sensing receptor antagonist | 0.023 0.008 DBMET02241 | DBMET02241 | |
| 0.003 | 0.911 | 0.144 | Anticonvulsant | 0.144 0.136 DBMET02241 | DBMET02241 | |
| 0.002 | 0.909 | 0.088 | Amidase inhibitor | 0.088 0.031 DBMET00484 | DBMET00484 | |
| 0.001 | 0.914 | 0.011 | Retinoic acid beta receptor antagonist | 0.011 0.009 DBMET00484 | DBMET00484 | |
| 0.001 | 0.919 | 0.062 | Glutamate (mGluR1) antagonist | 0.053 0.045 DBMET00484 0.062 0.037 DBMET02241 | DBMET02241 | |
| 0.002 | 0.928 | 0.024 | Thyroid hormone alpha agonist | 0.024 0.005 DBMET00484 | DBMET00484 | |
| 0.002 | 0.929 | 0.084 | Glutamate receptor agonist | 0.084 0.049 DBMET00484 | DBMET00484 | |
| 0.012 | 0.94 | 0.751 | Hematopoietic | 0.087 0.056 DBMET00484 0.751 0.003 DBMET02241 | DBMET02241 | |
| 0.005 | 0.934 | 0.155 | Dual specificity phosphatase inhibitor | 0.155 0.088 DBMET00484 | DBMET00484 | |
| 0.002 | 0.931 | 0.051 | Free fatty acid receptor 1 agonist | 0.051 0.005 DBMET00484 0.029 0.006 DBMET02241 | DBMET00484 | |
| 0.001 | 0.935 | 0.074 | Retinoid X beta receptor agonist | 0.074 0.004 DBMET00484 0.023 0.013 DBMET02241 | DBMET00484 | |
| 0.004 | 0.938 | 0.062 | Acetyl-CoA transferase 2 inhibitor | 0.062 0.028 DBMET00484 | DBMET00484 | |
| 0.002 | 0.937 | 0.05 | Prostaglandin EP3 antagonist | 0.028 0.023 DBMET00484 0.05 0.01 DBMET02241 | DBMET02241 | |
| 0.001 | 0.939 | 0.023 | Human T-cell leukemia virus type I protease inhibitor | 0.023 0.012 DBMET02241 | DBMET02241 | |
| 0.002 | 0.944 | 0.017 | Integrin beta6 antagonist | 0.017 0.005 DBMET00484 | DBMET00484 | |
| 0.009 | 0.956 | 0.107 | Electron transport complex I inhibitor | 0.107 0.068 DBMET02241 | DBMET02241 | |
| 0.025 | 0.977 | 0.116 | Papain-like protease (SARS coronavirus) inhibitor | 0.116 0.093 DBMET02241 | DBMET02241 | |
| 0.002 | 0.955 | 0.031 | Retinoic acid gamma receptor agonist | 0.031 0.006 DBMET00484 0.024 0.012 DBMET02241 | DBMET00484 | |
| 0.002 | 0.958 | 0.107 | GP IIb/IIIa receptor antagonist | 0.107 0.016 DBMET00484 0.051 0.032 DBMET02241 | DBMET00484 | |
| 0.002 | 0.959 | 0.082 | Prostacyclin antagonist | 0.074 0.006 DBMET00484 0.082 0.005 DBMET02241 | DBMET02241 | |
| 0.003 | 0.961 | 0.044 | Prostaglandin E2 antagonist | 0.044 0.043 DBMET00484 | DBMET00484 | |
| 0.002 | 0.966 | 0.033 | Renin inhibitor | 0.033 0.028 DBMET02241 | DBMET02241 | |
| 0.002 | 0.966 | 0.027 | Retinoic acid beta receptor agonist | 0.027 0.007 DBMET00484 | DBMET00484 | |
| 0.001 | 0.966 | 0.024 | Thyroid hormone alpha antagonist | 0.024 0.006 DBMET00484 | DBMET00484 | |
| 0.008 | 0.978 | 0.081 | Cathepsin E inhibitor | 0.081 0.022 DBMET02241 | DBMET02241 | |
| 0.004 | 0.975 | 0.153 | Platelet aggregation inhibitor | 0.153 0.125 DBMET00484 | DBMET00484 | |
| 0.002 | 0.974 | 0.03 | Integrin alphaVbeta1 antagonist | 0.03 0.006 DBMET00484 0.022 0.01 DBMET02241 | DBMET00484 | |
| 0.002 | 0.976 | 0.288 | Peroxisome proliferator-activated receptor delta antagonist | 0.089 0.006 DBMET00484 0.288 0.003 DBMET02241 | DBMET02241 | |
| 0.002 | 0.978 | 0.041 | Retinoid X gamma receptor antagonist | 0.041 0.004 DBMET00484 0.03 0.013 DBMET02241 | DBMET00484 | |
| 0.004 | 0.982 | 0.034 | Cholecystokinin B agonist | 0.034 0.031 DBMET00484 | DBMET00484 | |
| 0.001 | 0.979 | 0.014 | Calcium-dependent phospholipase A2 inhibitor | 0.014 0.006 DBMET02241 | DBMET02241 | |
| 0.013 | 0.991 | 0.1 | Factor V inhibitor | 0.1 0.069 DBMET00484 0.095 0.082 DBMET02241 | DBMET00484 | |
| 0.01 | 0.989 | 0.188 | ABCA1 expression enhancer | 0.188 0.011 DBMET00484 0.141 0.02 DBMET02241 | DBMET00484 | |
| 0.001 | 0.981 | 0.06 | Endothelin B receptor antagonist | 0.06 0.005 DBMET02241 | DBMET02241 | |
| 0.001 | 0.982 | 0.082 | Retinoid X gamma receptor agonist | 0.082 0.004 DBMET00484 0.027 0.013 DBMET02241 | DBMET00484 | |
| 0.002 | 0.984 | 0.039 | Protocollagen prolyl hydroxylase inhibitor | 0.039 0.008 DBMET00484 | DBMET00484 | |
| 0.003 | 0.987 | 0.04 | Erythropoietin receptor agonist | 0.04 0.029 DBMET00484 | DBMET00484 | |
| 0.002 | 0.986 | 0.094 | Endothelin receptor antagonist | 0.094 0.005 DBMET02241 | DBMET02241 | |
| 0.002 | 0.987 | 0.032 | Growth factor receptor-bound protein 2 antagonist | 0.032 0.031 DBMET00484 | DBMET00484 | |
| 0.011 | 0.996 | 0.134 | Sphingosine 1-phosphate receptor 2 agonist | 0.134 0.037 DBMET02241 | DBMET02241 | |
| 0.006 | 0.992 | 0.119 | MAP3K9 inhibitor | 0.119 0.116 DBMET02241 | DBMET02241 | |
| 0.004 | 0.99 | 0.072 | Sirtuin 1 inhibitor | 0.072 0.043 DBMET02241 | DBMET02241 | |
| 0.002 | 0.989 | 0.232 | Prostaglandin antagonist | 0.232 0.005 DBMET00484 0.212 0.006 DBMET02241 | DBMET00484 | |
| 0.002 | 0.989 | 0.028 | Liver X receptor alpha antagonist | 0.028 0.021 DBMET00484 | DBMET00484 | |
| 0.003 | 0.991 | 0.147 | Amyloid beta precursor protein antagonist | 0.147 0.104 DBMET00484 | DBMET00484 | |
| 0.005 | 0.992 | 0.032 | HCV polyprotein inhibitor | 0.032 0.031 DBMET00484 | DBMET00484 | |
| 0.003 | 0.991 | 0.136 | 5-Lipoxygenase inhibitor | 0.136 0.043 DBMET00484 | DBMET00484 | |
| 0.002 | 0.989 | 0.073 | Endothelin A receptor antagonist | 0.073 0.005 DBMET02241 | DBMET02241 | |
| 0.004 | 0.992 | 0.508 | Elastase 1 inhibitor | 0.129 0.009 DBMET00484 0.508 0.001 DBMET00489 0.063 0.057 DBMET02241 | DBMET00489 | |
| 0.002 | 0.99 | 0.025 | NMDA 2D receptor antagonist | 0.025 0.022 DBMET00484 | DBMET00484 | |
| 0.005 | 0.994 | 0.117 | Nav1.1 sodium channel blocker | 0.117 0.05 DBMET02241 | DBMET02241 | |
| 0.002 | 0.992 | 0.157 | Plasminogen activator inhibitor antagonist | 0.082 0.014 DBMET00484 0.157 0.005 DBMET02241 | DBMET02241 | |
| 0.003 | 0.993 | 0.083 | Adrenaline antagonist | 0.083 0.065 DBMET02241 | DBMET02241 | |
| 0.002 | 0.993 | 0.068 | Endothelin-converting enzyme inhibitor | 0.044 0.035 DBMET00484 0.068 0.021 DBMET02241 | DBMET02241 | |
| 0.003 | 0.993 | 0.085 | Antiadrenergic | 0.085 0.066 DBMET02241 | DBMET02241 | |
| 0.001 | 0.992 | 0.033 | Vitronectin receptor antagonist | 0.033 0.009 DBMET00484 | DBMET00484 | |
| 0.002 | 0.993 | 0.032 | Nicotinic acid receptor 2 agonist | 0.032 0.031 DBMET00484 | DBMET00484 | |
| 0.005 | 0.996 | 0.078 | 3C-Like protease (SARS coronavirus) inhibitor | 0.078 0.074 DBMET02241 | DBMET02241 | |
| 0.001 | 0.993 | 0.03 | Integrin alphaVbeta3 antagonist | 0.03 0.008 DBMET00484 | DBMET00484 | |
| 0.004 | 0.996 | 0.099 | Glucagon-like peptide 1 receptor antagonist | 0.046 0.017 DBMET00484 0.099 0.005 DBMET02241 | DBMET02241 | |
| 0.003 | 0.995 | 0.04 | Aggrecanase 1 inhibitor | 0.04 0.025 DBMET00484 | DBMET00484 | |
| 0.003 | 0.995 | 0.085 | Cathepsin D inhibitor | 0.085 0.023 DBMET02241 | DBMET02241 | |
| 0.001 | 0.994 | 0.085 | Integrin alpha4 antagonist | 0.085 0.007 DBMET00484 | DBMET00484 | |
| 0.001 | 0.993 | 0.034 | Integrin beta7 antagonist | 0.034 0.009 DBMET00484 0.03 0.01 DBMET02241 | DBMET00484 | |
| 0.003 | 0.995 | 0.068 | Elastase inhibitor | 0.049 0.043 DBMET00484 0.068 0.023 DBMET00489 | DBMET00489 | |
| 0.003 | 0.996 | 0.049 | Carbonic anhydrase II stimulant | 0.049 0.042 DBMET00484 | DBMET00484 | |
| 0.001 | 0.994 | 0.206 | Elastase 2 inhibitor | 0.027 0.011 DBMET00484 0.206 0.001 DBMET00489 | DBMET00489 | |
| 0.001 | 0.994 | 0.206 | Elastase 2A inhibitor | 0.027 0.011 DBMET00484 0.206 0.001 DBMET00489 | DBMET00489 | |
| 0.002 | 0.995 | 0.123 | Sphingosine 1-phosphate receptor 5 agonist | 0.103 0.008 DBMET00484 0.123 0.006 DBMET02241 | DBMET02241 | |
| 0.002 | 0.995 | 0.021 | Tryptophan hydroxylase 1 inhibitor | 0.021 0.006 DBMET00484 0.016 0.015 DBMET02241 | DBMET00484 | |
| 0.002 | 0.995 | 0.034 | Purinergic P2X3 antagonist | 0.034 0.024 DBMET02241 | DBMET02241 | |
| 0.003 | 0.996 | 0.268 | Chymotrypsin inhibitor | 0.268 0.005 DBMET00489 | DBMET00489 | |
| 0.002 | 0.995 | 0.055 | Integrin alpha5beta1 antagonist | 0.055 0.015 DBMET00484 | DBMET00484 | |
| 0.001 | 0.994 | 0.05 | Integrin alpha4beta7 antagonist | 0.05 0.005 DBMET00484 0.024 0.012 DBMET02241 | DBMET00484 | |
| 0.002 | 0.995 | 0.149 | Integrin antagonist | 0.149 0.01 DBMET00484 0.039 0.031 DBMET02241 | DBMET00484 | |
| 0.002 | 0.996 | 0.137 | Aurora-C kinase inhibitor | 0.137 0.069 DBMET02241 | DBMET02241 | |
| 0.003 | 0.997 | 0.056 | Integrin alpha1beta1 antagonist | 0.056 0.005 DBMET00484 0.038 0.029 DBMET02241 | DBMET00484 | |
| 0.002 | 0.996 | 0.06 | Neuropeptide agonist | 0.06 0.038 DBMET02241 | DBMET02241 | |
| 0.001 | 0.996 | 0.036 | AMPA receptor agonist | 0.036 0.023 DBMET00484 | DBMET00484 | |
| 0.001 | 0.995 | 0.077 | VLA-4 antagonist | 0.077 0.008 DBMET00484 | DBMET00484 | |
| 0.001 | 0.995 | 0.073 | Sphingosine 1-phosphate receptor 3 agonist | 0.073 0.009 DBMET02241 | DBMET02241 | |
| 0.001 | 0.995 | 0.061 | Complement C3a chemotactic receptor antagonist | 0.061 0.021 DBMET00484 0.057 0.023 DBMET02241 | DBMET00484 | |
| 0.001 | 0.995 | 0.022 | Integrin beta3 antagonist | 0.022 0.012 DBMET00484 | DBMET00484 | |
| 0.001 | 0.996 | 0.06 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.06 0.007 DBMET00484 | DBMET00484 | |
| 0.001 | 0.996 | 0.026 | Integrin beta5 antagonist | 0.026 0.01 DBMET00484 | DBMET00484 | |
| 0.001 | 0.996 | 0.126 | Prostaglandin D2 antagonist | 0.126 0.004 DBMET00484 0.095 0.005 DBMET02241 | DBMET00484 | |
| 0.001 | 0.996 | 0.06 | p53 inhibitor | 0.055 0.011 DBMET00484 0.06 0.009 DBMET02241 | DBMET02241 | |
| 0.001 | 0.996 | 0.167 | Estrone sulfatase inhibitor | 0.167 0.003 DBMET00489 | DBMET00489 | |
| 0.001 | 0.996 | 0.024 | Kainate receptor 4 antagonist | 0.024 0.018 DBMET00484 | DBMET00484 | |
| 0.002 | 0.997 | 0.109 | M17 leucyl aminopeptidase inhibitor | 0.109 0.09 DBMET00484 | DBMET00484 | |
| 0.001 | 0.996 | 0.019 | Kainate receptor 3 antagonist | 0.019 0.01 DBMET00484 | DBMET00484 | |
| 0.001 | 0.996 | 0.023 | Kainate receptor 5 antagonist | 0.023 0.013 DBMET00484 | DBMET00484 | |
| 0.001 | 0.996 | 0.04 | AMPA 2 receptor antagonist | 0.04 0.014 DBMET00484 | DBMET00484 | |
| 0.001 | 0.997 | 0.035 | Carbonic anhydrase I stimulant | 0.035 0.03 DBMET00484 | DBMET00484 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |